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Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 8 
 
 
 
 
© 2013 Foyaca Sibat and de Fátima Ibañez Valdés, licensee InTech. This is an open access chapter 
distributed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction 
in any medium, provided the original work is properly cited. 
Uncommon Clinical Manifestations of 
Cysticercosis 
Humberto Foyaca Sibat and Lourdes de Fátima Ibañez Valdés 
Additional information is available at the end of the chapter 
http://dx.doi.org/10.5772/53078 
1. Introduction 
Cysticercosis, a parasitic infection caused by the larval form of the pork tapeworm, Taenia 
solium, is increasingly recognized as a cause of epilepsy, headache, and neurological signs 
when it is located in the brain, optic nerve or spinal cord, known as neurocysticercosis 
(NCC). A high prevalence of cysticercosis/taeniosis has been reported from the developing 
countries because of the coexistence of poor sanitary conditions and domestic pig raising 
without veterinary control or surveillance systems. It occurs mainly in Eastern and Southern 
Africa, China, India, Mexico, Central America, Chile, Ecuador, Colombia, Venezuela, Peru, 
Brazil, Papua New Guinea, and non-Islamic South East Asia where human faces reach pigs 
and pork is eaten raw or undercooked.  
An infection which leads to extra-intestinal disease (including NCC) usually occurs as a 
result of eating food or drinking water contaminated by human feces containing T. solium 
eggs. It is a preventable and potentially eradicable neurological disease which primarily 
affects people living in the developing world. The disease is endemic in Central and South 
America, Asia and Africa. There is a variable time interval between point of infection and 
the onset of symptoms: ranging from 1-30 years.  
Seizures are widely reported to be the most common symptom, occurring in 70-90% of 
patients. Most patients respond to praziquantel if cystic lesions are located in the 
parenchyma tissue and albendazole when parasites are located in the ventricular system 
and subarachnoid space [1-16]. Seizure disorder is the most frequent clinical manifestation 
of the NCC observed in 50% to 80% of cases, in children and adults presenting 
intraparenchymal cystic lesions. [13-44] 
Each day the cysticercosis is more and better known in the developed world or in 
developing countries, the immune diagnostic techniques are more reliable and 
neuroimaging studies are more accurate. The greatest success in the diagnosis of the disease 
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control passes at the achievements attained by the agricultural sector, without which it is not 
possible try to sustain successful results. The knowledge that we have on the porcine 
cysticercosis today are much more certain and deep. In the epidemiological aspects, the 
African continent goes up to the head because it is the only basic information that has been 
made safe for almost all their countries, as can be seen in the chapter: “Agricultural Impact of 
Porcine Cyisticercosis in Africa: A Review” in this book written by Helena A Ngowi et al. This 
study included information from 54 African countries that were fully recognized by the 
United Nations as of 2012. The total population of pigs estimated in the study area in 2010 
amounted 29,606,438. This was approximately 3.1% of the world pig population estimate (N 
= 965,855,414) of 2010. Out of the Africa regional pig population, approximately 0.2% was 
reared in the northern countries, while 6.1%, 43.3%, 16,4%, and 34.0% were reared in the 
southern, western, central, and eastern Africa, respectively. Overall, 19 (35.2%) of the 54 
study countries reported prevalence of cysticercosis in pigs. While no data were available in 
the northern region, the remaining regions provided prevalence data, with more reporting 
frequency observed in the Eastern followed by Central Africa. 
All these previous arguments together have favored the growing number of diagnosed 
uncommon presentations of cysticercosis that before passing unnoticed. 
For purely didactic reasons we are going to aggregate all the uncommon forms of 
cysticercosis in accordance with the following classification: 
 Uncommon cysticercosis in the head and neck 
 Uncommon cysticercosis in the trunk 
 Uncommon cysticercosis in the abdomen 
 Uncommon cysticercosis in the limbs 
2. Uncommon cysticercosis in the head and neck 
2.1. Uncommon clinical presentations neurocysticercosis (UNCC) 
Pseudoseizures and epilepsy in patients presenting neurocysticercosis 
In our experience, the South African patients with NCC and fictitious attacks (pseudo-
seizures) are more often in young women with a history of violations and/or sexual abuse and 
their attacks are usually characterized by absence of post ictal signs, irregular and 
asymmetrical stereotyped movements, and often accompanied by shouts or sounds in the 
middle of the “attack” that usually last for more than three minutes if the patients are not 
alone. We found that these manifestations contribute to characterize clinically patients with 
pseudo-crisis. These conclusions were the result of a study conducted some years ago. [4] 
Refractory epilepsy in HIV/AIDS patients presenting NCC 
At the present moment, more than 40 million people are living with HIV and more than 50 
million people have neurocysticercosis (NCC) worldwide. About 5% of patients with HIV 
and most of the patients with NCC develop recurrent epileptic seizures. Although this 
comorbidity has not been reported as an additional public health problem, NCC and the 
HIV/AIDS infections are very common in the former Transkei (South Africa) and both cause 
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recurrent epileptic seizures frequently. [3,5] Usually patients with NCC have partial seizures 
with or without secondary generalization. The epileptogenesis in patients with NCC can be 
attributed to several factors, such as: inflammation, gliosis and its frequent location in the 
frontal and temporal lobes. [47] While the basis for seizure production in HIV-positive patients 
include HIV itself, mass lesions, meningitis, encephalitis, ischemia, metabolic derangement, 
and drugs [48] In both conditions we recognize patients as epileptic when they present 
recurrent unprovoked epileptic seizures associated to a chronic brain disorder. [14] 
We consider refractory epilepsy when seizures are so frequent that limit the patient’s ability 
to live fully in line with their wishes and their physical and mental capabilities or when the 
antiepileptic drug (AED) does not control the crisis or their side effects are limited to a 
person’s normal development. [6] Other authors have the same criteria. [49] Recently, The 
International League against Epilepsy has defined the patients with epilepsy resistant to 
drugs when there are no controls over the attacks with a combination of two AED well 
tolerated, and managed properly elected. BY understanding how the lack of control when 
the patients continue to have attacks with an interval of not less than one third of which 
presented before starting the antiepiileptic treatment [14] 
Although this clinical presentation is not uncommon in our setting it may be very 
uncommon in other countries. Nevertheless, there is a novel presentation of motor partial 
simple seizures localized in the lower part of the hemiface in females at the stage IV of 
HIV/AIDS and CD4 below 100 x106. This type of seizures becomes secondarily generalized a 
few days or weeks of the beginning and are still uncommon in our region. At the present 
moment the mortality rate for these patients is 100%. 
Managing seizures in HIV-positive patients present specific challenges, including the 
identification and treatment of the underlying cause, recognition that seizure production 
may be multifactorial, selection of the appropriate AED, and consideration of the effects of 
co-administered highly active antiretroviral therapy (HAART). Unfortunately, there has 
been little systematic study in these areas. The available information is confined to case 
reports, retrospective analyses, and small studies. [48] The cause of the seizures will depend 
on the stage of HIV infection. Since the causes are many and there may be more than one 
mechanism for seizure production, a meticulous clinical, laboratory, and neuroimaging 
survey must be undertaken. The older AEDs, phenobarbital, phenytoin, carbamazepine, and 
valproic acid are still widely used. [48] In our experience Valproic acid is the AED of choice 
for HIV/AIDS patients with epilepsy due to NCC and we did not find increased viral load in 
our series of these patients on HAART. 
Finally we like to highlight that apart from NCC/HIV/AIDS sometimes other causes should 
be investigated for a better control of the seizures. [9] 
Dementia is another uncommon presentation of NCC [50] and its prognosis is better if there 
is not an associated HIH/AIDS. 
Massive neurocysticercosis 
Massive brain infection with viable cysticerci, undetectable inflammatory reaction on CNS 
imaging, and an unexpectedly high (82%) prevalence of tapeworm infection represents a 
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particular presentation of neurocysticercosis is different from the previously described 
syndromes of cysticercotic encephalitis and disseminated systemic cysticercosis according 
with Garcia et al. [51] In our series we did not find remarkable differences excepting a fatal 
prognosis when more than one thousand of cystic lesions are present [14,16] but without 
doubt it is another uncommon clinical presentation of NCC. (Figure 1) 
 
Figure 1. CT scan of the brain showing massive neurocysticercosis (more that 100 cysts) 
Giant intraparenchymal/Giant subarachnoid neurocysticercosis 
Parenchymal cysts usually involve the gray white matter junction, however giant cyst is 
usually located at the Sylvia fissure or deeper in the cerebral lobe. 
Giant NCC is a rare condition defined by various authors as measuring more than five cm in 
its largest dimension [52] usually associated with intracranial hypertension but giant cysts 
may not always be associated with elevated intracranial pressure, probably due to slow 
growing of the cyst. 
Almost all reported patients presenting intraparenchymal giant cyst had similar clinical 
manifestations at the beginning characterized by headache, altered mental status, 
hemiparesis mainly on the right side [9, 53-62] or uncontrolled epilepsy. [63] Between 1990 
and 2006, only five patients have been reported in South Africa. All had associated epilepsy, 
one patient also presented visual hallucinations, dysnomia in blue and red, dyslexia and 
palinopsia, and the cyst (106mm) was located in the left occipital lobe. [9] (See figure 2)  
All patients were treated with a 31-day course of praziquantel 50 mg/kg daily. Two patients 
had corticosteroids administered simultaneously. All five patients had anticonvulsant cover. 
In all cases there was rapid and complete resolution of the cysts. In three patients this 
occurred within 30 days. The computed tomographic features of giant cysticercal cysts in 
our series were: thin walled cystic lesions containing clear fluid, localized thickening of the 
wall with an eccentric scale in three patients, the absence of pericyst edema, and the 
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presence of associated smaller and more typical cysticercal larval forms. Identification of a 
scolex in a cystic lesion with CSF intensity plays a key role in the diagnosis of NCC and the 
presence of internal septations is an atypical feature. [61] 
Giant cysticercal cysts resolve remarkably rapidly on medical therapy. A therapeutic trial of 
praziquantel can, in suspected giant cysticercal cysts, obviate the need for exploratory 
craniotomy. [9, 56] Other authors [60] suggest repeating anthelmintic treatment to provide 
good response, when it is necessary, and we fully agree on that. However, surgical 
treatment may be required when it is associated with elevated intracranial pressure, [62] 
mainly if the pre-operatory diagnosis is not clear enough. 
 
Figure 2. In upper right and lower left white arrow show identification of active viable cyst in vesicular 
stage with an eccentric scolex. Giant cyst measuring 106 mm on the left occipital lobe is seen. 
Neurocysticercosis in the posterior cranial fossa 
The posterior cranial fossa is part of the intracranial cavity, located between the foramen 
magnum and tentorium cerebelli. It contains the brainstem and cerebellum. This is the most 
inferior of the fossa. It houses the cerebellum, medulla and pons. Anteriorly it extends to the 
apex of the petrous temporal. Posteriorly it is enclosed by the occipital bone. Laterally 
portions of the squamous temporal and mastoid part of the temporal bone from its walls. 
In the posterior fossa, NCC can involve the fourth ventricle, cerebellopontine angle cistern, 
cisterna magna and rarely, the cerebellum [64, 65] .Cysticercosis affecting one of the above-
mentioned anatomical structures are grouped under the name of NCC of the posterior fossa 
(PFNCC).  
One of the first articles about clinical manifestations was done by Bickerstaff et al., in 1956 
[66] and about clinical and surgical management by Kla in 1964. [67] Other modalities of 
management including the diagnostic importance of laboratory and serological analysis of 
blood and cerebro-spinal fluid in cysticercosis of the posterior cranial fossa and description 
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of the pseudotumoral form of Cysticercus cellulose to be remembered when one attempts to 
characterize the type of neoplasms of the posterior fossa as detected by brain scan in the 
infantile population were reported from 1971 and 1978. [68-71] 
Anecdotal clinical presentations in patients with posterior fossa involvement may include 
signs of bilateral fourth nerve palsy, facial myokymia, upbeat nystagmus, periodic 
alternating nystagmus, and rhythmic oculopalatal myoclonus. [72] In patients presenting 
huge cystic lesions due to PFNCC then intermittent severe headache, epilepsy, and signs of 
raised intracranial pressure, cerebellar signs and cranial nerves signs can be seen. [63,73] 
Studies post-mortem have confirmed this correlation between signs of increased intracranial 
pressure, localizing cerebellar signs and even hearing loss in patients presenting PFNCC in 
the cerebellopontine cistern and obstructive hydrocephalus. [74,75] 
Sang-Wook et al. [76] reported a case presenting headache, dizziness, drowsiness and ataxic 
gait. The magnetic resonance imaging showed hydrocephalus and an ill-defined, multicystic 
cerebellar mass with hypersignal on T2-weighted images, hyposignal on T1-weighted 
images and rim enhancement after gadolinium injection (the differential diagnoses of 
include abscess, tuberculosis, metastasis and other parasitic diseases). The patient 
underwent endoscopic third ventriculostomy and the cyst resection was done through a 
craniotomy. In surgical field, cysts were conglomerated in a dense collagen capsule that 
were severely adherent to surrounding cerebellar tissue, and transparent cysts contained 
white, milky fluid. Histological findings confirmed the diagnosis of cysticercosis. These 
authors concluded that racemose cysticercosis is rare in the cerebellar hemisphere but 
neurocysticercosis should be taken into consideration as a differential diagnosis of multiple 
cystic lesions in the cerebellum and we agree on that. As has been mentioned, T solium 
cysticercosis spread through the bloodstream and it may locate almost anywhere in the 
CNS, most frequently involves the cerebral hemispheres and sometimes ventricles, basal 
cisterns, subarachnoid space, and spinal cord. Cerebellar cysticercosis has been rarely 
reported [77-78]. Anecdotal presentations include multiple cranial nerve involvement (V, VI, 
VII, VIII) and cerebellar signs resembling anterior inferior cerebellar artery (AICA) 
syndrome. [79]  
Other uncommon clinical locations of NCC (UNCC) are: intraventricular (IV), intra-spinal 
(IS), subarachnoid (SA) and others that we will explain below.  
2.1.1. Neurocysticercosis intraventricular (IVNCC) 
The ventricular system is a set of structures containing cerebro-spinal fluid in the brain. It is 
continuous with the central canal of the spinal cord. The ventricles are filled with cerebro-
spinal fluid (CSF) which bathes and cushions the brain and spinal cord within their bony 
confines. Cerebro-spinal fluid is produced by modifying ependymal cells of the choroid 
plexus found in all components of the ventricular system except for the cerebral aqueduct 
and the posterior and anterior horns of the lateral ventricles. CSF flows from the lateral 
ventricles via the foramina of Monro into the third ventricle, and then the fourth ventricle 
via the cerebral aqueduct in the brainstem. From there it can pass into the central canal of 
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the spinal cord or into the cisterns of the subarachnoid space via three small foramina: the 
central foramen of Magendie and the two lateral foramina of Luschka. The fluid then flows 
around the superior sagittal sinus to be reabsorbed via the arachnoid villi into the venous 
system. CSF within the spinal cord can flow all the way down to the lumbar cistern at the 
end of the cord around the cauda equina where lumbar punctures are performed. 
The aqueduct between the third and fourth ventricles is very small, as are the foramina, 
which means that they can be easily blocked, causing high pressure in the lateral ventricles. 
This is a common cause of hydrocephalus (known colloquially as "water on the brain"), 
which is an extremely serious condition due to both the damage caused by the pressure as 
well as the nature of whatever caused the block (e.g. a tumour, cyst or inflammatory 
swelling). The cavities of the cerebral hemispheres are called lateral ventricles, or 1st & 2nd 
ventricles. These two ventricles open commonly into the 3rd ventricle by a common opening 
called the foramen of Monro. 
The presence of T solium in the ventricular system may be seen in a 7-30% of patients with 
NCC [45] and although it has been reported less frequently (6 %) by other authors [46] 
everything seems to indicate that its frequency is much greater than had been thought 
previously. [45] Of all forms of presentation of the NCC, the IVNCC is sometimes associated 
with a fatal prognosis. The diagnosis of certainty is achieved by methods of neuroimaging, 
particularly the nuclear magnetic resonance imaging (MRI), which is also indispensable as 
prior checking to surgery, the choice of treatment and assessment of the response to the 
same. [80-82] 
Some reports related to the clinical characteristics and the management of this entity 
confirm their increasing frequency in countries such as the Unite States of America. [83, 84] 
In 1906, Ludwig Bruns described a phenomenon characterized by sudden headache 
associated with acute vestibular syndrome, triggered by sudden movements of the head, or, 
at times, it could have a disastrous outcome, by leading to coma and even death. [85] A form 
of presentation of the NCCIv may be syndrome Bruns characterized by episodes of loss of 
consciousness to head movements and hydrocephalus due to a cyst in the IV ventricle their 
movement obstructs the exit of CSF through the holes of Luchka and Magendie, involuntary 
movements or intracranial hypertension. [86] Other clinical manifestations of the NCCIv 
have been reported according to the location of the cysticerci in the ventricular system [87] 
or when passing through the same. [88] The NCCIv of the lateral ventricles has not been 
reported that constitutes a diagnostic or therapeutic problem however the NCCIv of the III 
and IV ventricles constitute a major challenge to resolve. [80,89] The treatment of forms Iv is 
geared toward case by case, according to the pathogenic substrate. The first thing to define 
is the presence or risk of acute hydrocephalus, and, therefore, the option of a 
ventriculostomy emergency or making a ventriculoperitoneal shunt (DVP), with or without 
fenestration of the septum, according to the location of the Ct. To take the decision to 
remove the cysts must be taken into account: the number, location stage of cysticercus, 
general clinical conditions of the patient, abilities, and experience of the surgical team  to 
perform open or endoscopic neurosurgical approach. [90, 91] Also add to the list other 
criteria such as: the mass effect, the ventricular obstruction, the dysfunction of the valve and 
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the diagnostic doubt. [90] Some authors have argued that the confirmation of contrast in the 
wall cysticercus by MRI is a sign of a poor prognosis independent of the applied surgical 
treatment, as it translates the possibility of a process of ependimitis that will tend to 
chronicity with obstruction or entrapment, independent of the presence of the Ct. [90] The 
treatment of forms Iv includes not only surgical options, but also with anti-parasitic 
treatment (APT), corticosteroids [87, 90-93] and VPS when necessary. It is important to 
mention that the APT of the NCCIv should be indicated if there is a possibility to make an 
emergency-relief through a VPS in the case of acute obstruction. Variations in the number, 
volume and involution of the Ct, the secondary reactions, the eventual hydrocephalus, as well 
as the low number of patients who have this form of presentation, make it unlikely to carried 
out randomized clinical trials with an acceptable confidence. [94] On the other hand, 
Ramirez-Ceballos and Marquez [97] argue that the NCCIv requires an individualized 
treatment, medical, surgical, or a combination of both and in their experience Iv neuro-
endoscopic has provided a good surgical approach allowing to explore properly the 
ventricular cavities with either the rigid or flexible endoscope. According to these authors, 
this treatment improves the prognosis and clinical course of patients, since in most of them it 
avoids the placement of derivatives systems and in those cases that require, decreases the 
risk of re-surgical interventions. In this regards, we did not find articles related to the 
NCCIv and infection by HIV/AIDS, its clinical features and treatment options therefore it 
will be another aspect to be discussed below from our results. 
 
Figure 3. CT scan of the brain showing asymmetrical hydrocephalus due to intraventricular 
neurocysticercosis blocking foramen of Monro on the right side and calcified NCC. 
Patients presenting intraventricular NCC (IvNCC) can have a different clinical presentation 
if they are HIV positive [2,3], although they have in common that the diagnosis must be 
confirmed by MRI as other have also pointed outr. [80, 97, 98] Should be emphasized that in 
HIV patients must be ruled out the presence an associated chronic meningitis by favoring 
the ventricular dilatation, (See figure 3) and in which case the serial lumbar punctures 
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should be assessed carefully. The ABZ is the drug of choice, [2,3] if removal of the Ct by 
endoscopic is not possible. [15,16,90, 91]  
Fourth ventricular neurocysticercosis (FVNCC) 
Despite fourth ventricle is located in the posterior fossa, we decided to place apart here for 
didactic purposes, and because the fourth ventricle is the most frequent site of 
intraventricular infestation, a location that carries a higher risk of raise intracranial pressure 
due to cerebro-spinal fluid (CSF) blockage. We will comment a little bit more about this 
particular location of T solium cysticercosis. 
The fourth ventricle is one of the four connected fluid-filled cavities within the human brain. 
These cavities, known collectively as the ventricular system, consist of the left and right 
lateral ventricles, the third ventricle, and the fourth ventricle. The fourth ventricle extends 
from the cerebral aqueduct (aqueduct of Sylvius) to the obex, and is filled with CSF. The 
fourth ventricle has a characteristic diamond shape in cross-sections of the human brain. It is 
located within the pons or in the upper part of the medulla. CSF entering the fourth 
ventricle through the cerebral aqueduct can exit to the subarachnoid space of the spinal cord 
through two lateral foramina of Luschka and a single, midline foramen of Magendie. 
Clinical and imagenological aspects on FVNCC has been described in the medical literature 
[99- 108] and can be sumarized as follow: Symptoms and sings of intracraneal hypertension 
due to obstructive hydrocephalus [99,100-107] , blurred vision, loss of consciousness, [100] 
sudden death, [108] reversible parkinsonism following ventriculoperitoneal shunt, [109] 
Bruns syndrome, [110] positional vomiting [111] and comatose state [112] 
From the point of view of imagenology, the magnetic resonance imaging (MRI) is the 
investigation of choice which can also show: cerebrospinal fluid (CSF) signal intensity (on all 
pulse sequences), intra fourth ventricular cyst with scolex, and wall enhancement. On T1-
weighted and Fluid Attenuation Inversion Recovery images (FAIR), the cyst wall and scolex 
which are not seen in other routine sequences, and the CSF flow study can show the 
intraluminal nature of the cyst [113] and the even imagenological appearance of multicystic 
tumor. [114]  
Most studies have been addressed to review the therapeutic approaches of IVNCC, as can 
be seen in our review. [99,110,115-127] and has been well established that available 
treatment options are: medical, external cerebro-spinal fluid diversion, microsurgical, or 
endoscopic removal alone or in combination. [122] Summarizing the reports in the medical 
literature we can conclude that the best choices for treatment of IVNCC are:  
1. Albendazol (15 mg/kg/day for 2 weeks): A regimen of albendazole is the treatment of 
choice for IVNCC even after surgical procedures [122], although praziquantel may also 
be useful. [117] 
2. Praziquantel (100 mg/kg/day for 2 weeks): Rapid regression of a large cyst of the fourth 
ventricle after oral praziquantel, avoiding the need for surgery has been reported. [116] 
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3. Direct surgical excision of the parasite after a shunt procedure is performed, [115] but 
the complication rate is high due to obstruction or material infection, which may justify 
other procedures such s endoscopic third ventriculostomy, [122] as you can read below. 
Resection of the fourth ventricle lesion through a sub occipital approach allowed for 
restoration of normal cerebro-spinal fluid (CSF) flow and relief of midbrain 
compression. [112] 
4. If pericystic enhancement is present on MRI, shunt surgery should be performed, and 
craniotomy reserved for treatment of those patients with symptomatic lesions 
secondary to mass effect.[119] 
5. Endoscopy approach: Neuroendoscopy provides a safe and effective management 
modality for the treatment of a variety of intracranial disorders, either temporal or non-
tumoral, congenital, developmental, and degenerative, and its knowledge, indications, 
and limits are fundamental for the armamentarium of the modern neurosurgeon. [126] 
In patients presenting symptomatic obstructive hydrocephalus, aqueductal and 
foramen of Monro dilatations, endoscopic neurosurgery is a minimally invasive 
technique enabling removal of intraventricular cyticercal cysts from all locations, 
avoiding major craniotomies/posterior fossa explorations and shunts. The flexible 
fiberoptic scope is used for excising cysts in the fourth ventricle, through a 
transaqueductal route and patients should be treated with albendazole in the 
postoperative period. [118, 120, 122] Endoscopic third ventriculostomy for patients with 
ventricular outlet obstruction and a prior history of FVNCC has been reported as a 
successful management and no patient has required subsequent surgery. [121, 122] 
Endoscopic transaqueductal removal of fourth ventricular neurocysticercosis with an 
angiographic catheter has been used and there are good experiences from two series of 
10 and 21 patients with IVNCC with obstructive hydrocephalus that underwent 
endoscopic removal along with endoscopic third ventriculostomy through a frontal 
precoronal burr hole. The author concluded that a 30-degree rigid telescope provide 
excellent image quality, with the ability to address intra-FVNCC through the dilated 
aqueduct with a curved-tip catheter without significant operative or postoperative 
complications. They concluded that neuro-endoscopic surgery is an effective treatment 
modality for patients with intraventricular NCC. It effectively restores CSF flow and is 
capable of removing cysts completely or partially from accessible locations causing 
mass effect. Partial removal or rupture of the cyst does not affect the clinical outcome of 
the patients. [123, 124] Other series of patients (n-13) presenting FVNCC with complete 
excised of cyst by using a transventricular, transaqueductal "scope-in-scope" endoscopic 
technique was reported and their author also concluded that endoscopic fourth 
ventricular cysticercal cyst excision along with internal cerebrospinal fluid diversion via 
endoscopic third ventriculostomy is an effective alternative to open microneurosurgical 
procedures and avoids shunt placement and its related complications [125] such as: 
Parkinsonism with evidence of midbrain dysfunction due to aqueductal stenosis after 
placement of ventriculoperitoneal shunt. [110] 
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2.1.2. Subarachnoid NCC (SANCC) 
In the central nervous system, the subarachnoid space (SAE) is the interval between the 
arachnoid membrane and pia mater. It is occupied by spongy tissue consisting of trabeculae 
(delicate connective tissue filaments that extend from the arachnoid mater and blend into 
the pia mater) and intercommunicating channels in which the CSF is contained. 
This cavity is small on the surface of the hemispheres of the brain. On the summit of each 
gyrus the pia mater and the arachnoid are in close contact, but in the sulci between the gyri, 
triangular spaces are left, in which the subarachnoid trabecular tissue is found. Whilst the 
pia mater closely follows the surface of the brain and dips into the sulci, the arachnoid 
bridges across them from gyrus to gyrus. 
At certain parts of the base of the brain, the arachnoid is separated from the pia mater by 
wide intervals, which communicate freely with each other and are named subarachnoid 
cisternæ; in these the subarachnoid tissue is less abundant. The subarachnoid space is the 
location of the interface between the vascular tissue and the cerebro-spinal fluid and is 
active in the blood brain barrier. 
The arachnoid mater continues down the spinal cord, and the subarachnoid layer with it. It 
serves a similar function in the spinal cord as it does in the brain. 
Despite SANCC is an uncommon location compare with intraparenchymal NCC, the 
commonest location in the subarachnoid space is over the cerebral hemispheres.  
In 2004, Wallin and col. [128] reported the prevalence of SANCC in 2% while other authors 
reported a higher prevalence (3.5 %) in patients with SANCC with visual and hormonal 
disturbances secondary to a direct compression of the pituitary stalk and the optic nerve, 
[129,130] in some studies it was not clear whether refers to the frequency of complications 
by compression of the optic nerve and the pituitary stalk within the group of patients with 
SANCC or within a group of patients with NCC in general. As in the above situations, the 
treatment of choice for the SANCC is individual. [94] There are numerous reports of cases 
and a series of cases treated with cesticidas and corticosteroids to repetition, but not 
compared with a control group, to confirm this hypothesis with the additional benefit of 
reducing the size of the cysts or of the inflammatory leptomeningeal process. [131,132] 
Despite the lack of evidence which originated in randomized clinical trials, there is 
consensus for this option [133] and other authors combine prolonged treatments (sometimes 
for several months) with cesticidas and corticosteroids. [134]  According to some authors the 
reason why the clinical manifestations of ischemia with or without infarction, due to 
cerebral vasculitis infectious by NCC, were not detected in some patients is due to the age 
group with the highest incidence have no aggregated vascular risk factors. The 
cerebrovascular complications are predominantly associated with the prevalence of the CC 
especially in the basal cisterns and associated arachnoiditis of variable degree [133, 135-139] 
later we will discuss this aspect based on our experience and results. It is known that when 
cisticerci are confined to a small area with associated arachnoiditis and few changes in the 
CSF, these affect small blood vessels predominantly penetrating arterioles causing 
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infarctions very similar to the lacunar infarctions of the basal ganglia which did not differ 
from those caused by arteriopatías or microateromas. [94] The most severe form of 
vasculopathy infectious for NCC is observed when the CC spreads through the SAE with 
major alterations of the LCR and a chronic evolution of the disease. The neurovascular 
syndrome (SNv) is usually the first manifestation of the focal SANCC that produces unique 
infarcts (90 %), which often have a good prognosis. [94] In contrast, many patients have non-
vascular complications (including intracranial hypertension and a progressive neurological 
impairment) when the NCC is diffusely extended in the CNS, whereas the SNv occurs only 
late in the course of the disease and has a grim forecast. [94] We have not found in the 
reviewed medical literature references related to the SANCC (See figure 4) and 
cerebrovascular complications in patients with HIV/AIDS. 
 
Figure 4. Racemose cystic lesions in left frontal and both temporal lobes. Intraventricular cyst causing 
obstructive hydrocephalus. 
The SANCC also has some different features in the South African patient due to their 
frequent association with HIV infection. As is known, scattered Ct in the SAE cause the most 
severe forms of infectious vasculitis when evolve toward the chronicity [ 94], although no 
one knows the exact prevalence of this problem. [ 16] In our study we were able to 
determine that the risk to present an ischemic infarct is almost three times higher in patient 
with SANCC compared with the patient with intraparenchymal NCC and this risk increase 
more than seven times if the patient is HIV-positive. Therefore you have to exhaust all the 
possibilities of deworming to avoid cerebrovascular complications. [16] 
2.1.3. Intraspinal NCC 
The intra-spinal NCC (ISNCC) presentation include: Intra-medullary NCC (IMNCC) and 
extra-medullary NCC (EMNCC). The ISNCC is rare and there are only 45 cases reported in 
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medical literature. Its frequency varies between 7 and 5.8 % and  its incidence is very low 
but six times more on that in axial medullary. [140, 141] Other authors in 2002 reviewed  of 
95 published cases of medullary cysticercosis since 1856. [142]  
Its clinical manifestations are the result of the presence of CC in the intra-spinal canal i.e. the 
space between the meninges of the spinal canal.[143] Other authors have found up to 200 
cases reported in the international medical literature before the year 2001, [144]  this low 
prevalence of the IMNCC is explained by the fact that the blood supply to the spinal cord is 
100 times less than the blood flow to the brain [145, 146] and the Ct usually comes to the 
region’s best irrigated. Most of the times the symptoms of the ISNCC are secondary to the 
mass effect or the secondary edema, and among the most common can be found: spastic 
paraplegia, bladder incontinence, radicular pain or sexual impotence; the degree of 
commitment depends on the site which locate the lesion. [147] When there is an  associated 
arachnoiditis (EMNCC) dominate the radicular pain and muscle weakness and when it 
affects the axial medullary then the predominant clinical feature is similar to the transverse 
myelitis characterized by sphincter dysfunction with motor and sensory signs  below the 
level of the lesion. [148] 
In ISNCC the subarachnoid damage can be secondary to its spread through the SAE, and 
the more usual imaging presentation is the  EMNCC and arachnoiditis. The IMNCC 
presentation has been associated with hematogenous spread or through the spinal canal; the 
latter is seen as expansive lesions with a ring enhancement after contrast injection. [141] This 
presentation is extremely rare, and the lesions may be single or multiple, or even with the 
appearance of clusters. [149] When there is a degenerative process of the cystic lesion can 
also be seen this thickening in the ring of the cystic wall after the administration of contrast 
during a CT scan of the thoracic spine. [141,143, 147,150-152] It is equally unusual the 
damage of the spinal canal and the most frequent space occupies lesion to level EM. As we 
before-mentioned, on very rare occasions IMNCC is confirmed. [153]  The differential 
diagnosis for the IMNCC presentation includes the IM abscess [154], other parasitic diseases 
such as hydatid cysts, neoplasias (ependymomas), traumatic lesions, sarcoidosis [155], 
arachnoid cysts [156], ependymal cysts [157] and neuroenteric cysts. [158] In the 
presentation EM include congenital cystic lesions (dermoides cysts); infectious diseases, 
demyelinating disorders, inflammatory or granulomatous, such as tuberculosis and 
sarcoidosis, and neoplasms. The region of provenance of the patient and the characteristics 
of the MRI images help to establish the difference. [159,160] For this type of presentation 
there is a general consensus on the poor knowledge and limited experience of the problem. 
Surgical treatment is recommended alone or combined with APD and corticoids [133, 161], 
although others believe that surgery is the best treatment option for NCCIm counting with 
current techniques of microsurgery. [141] The recovery of patients with IMNCC with 
surgical treatment is fast, with ranges of a week with maximum recovery of 3 months after 
surgery. [162] Although they have also reported irreversible spinal injuries by NCCIm that 
logically do not recover with surgical intervention. [141] Finally, there are individual 
differences from the clinical point of view, imaging and of response to treatment according 
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to the number and location of the lesions, that determine the characteristics of the 
presentations described [117,161] and which are by describing such as: medullary  central 
cord syndrome, medullary conus and the horsetail, when this happens. In the meantime, 
report of isolated cases continues to unfold with more or less variations between the same. 
[162,163] We report a HIV patient presenting intraspinal calcified NCC and an associated 
tuberculosis of the spinal. [11] The clinical and imagenological features of NCC and TB of 
the spine in HIV-positive patients have not been previously reported. (See figure 5)  
We have also seen patients with intramedullary granulomatous lesions and associated 
paravertebral calcified cysticercosis confirmed by biopsy and antigen/antibody cysticercosis 
serology test. (See figure 6) 
 
Figure 5. Shows calcified intramedullary calcified lesion and tuberculosis of the spine. 
We will not discuss this observation in this chapter because we consider that this is just an 
anecdotal case that provides only casual interesting information. Some author thinks that 
EMNCC is explained by the downward migration of larvae from the brain to the spinal 
subarachnoid space and most larvae are expected to be stopped in the upper portions of the 
spinal canal due to peculiarities of the anatomy of the spinal cord; because it is hard to 
image cysticerci passing throughout foramen of Luscka and Magendie others authors 
support the hematogenous route. [11, 142, 163] Spinal intramedullary cysticercosis involving 
the conus medullaris is an extremelly uncommon clinical condition that may mimic an 
intramedullary tumor. It should be kept in mind in the differential diagnosis of 
intramedullary conus lesions and to rememeber that it can lead to irreversible neurological 
deficits if untreated.[164] Another clinical presentation is spastic paraplegia in patients 
presenting dorsal IMNCC but in some of them the neurological deficit may persist even 
after successful cyst excision. [165] Coexisting intramedullary schwannoma with 
intramedullary cysticercus has been reported. [166] 
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Figure 6. Multiplanar, multisequence MRI of the spine with IV contrast: Shows intramedullary ring 
enhancing lesion at the level of T11/T12 with enhancement of the meninges and nerve roots due to 
tuberculous radiculomyelitis, tuberculoma and calcified cysticercosis in the paravertebral muscles. 
Disseminated cysticercosis  
In the chapter entitled: “What is a low frequency of the disseminated cysticercosis suggests 
that neurocysticercosis is going to disappear?” Our readership will find detailed 
information about this uncommon presentation of cysticercosis. Therefore in this chapter we 
are going to mention only some remarkable issues. 
Disseminated cysticercosis (DCC) was reported in 1912 by doctors of the English Navy 
stationed in India. An intensive search in PubMed revealed 22 cases reported by Wadia and 
collaborators in 1988 and only 16 additional cases were reported until 2006. [167]  Two years 
later Bhalla et al., (2008) argued that fewer than 50 cases have been reported in the 
international medical literature most of them from India. [168] The characteristic features of 
the DCC is epilepsy, subcutaneous cysticercosis, the pseudo-hypertrophy in the four 
members and the allocation of any other organ or system. [164] However, a manifestation 
fairly typical of the DCC may be a subcutaneous cyst that occurs as an asymptomatic 
nodule. These subcutaneous nodules can be sliders in the muscle and measure up to 1.5 cm. 
(See figure 6) In the case of patients who have had for more than 5 years cysticerci, these 
cysts are calcified. [169] Finally, there are individual differences from the clinical point of 
view, imaging and of response to treatment according to the number and location of the 
lesions, that determine the characteristics of the described presentations. [117,160] 
Neurocysticercosis is always present in patients with DCC.  
3. Other uncommon presentations of neurocysticercosis 
The unusual location of the cysts may result in uncommon manifestations mimicking a host 
of neurological disorders. Thus, a high level of suspicion should be kept for NCC, especially 
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in endemic zones and developing countries. Uncommon clinical presentations that 
demonstrate the spectrum of pleomorphism of NCC include extrapyramidal disease 
(parkinsonism and focal dystonia), Kluver-Bucy syndrome, Weber's syndrome, dementia 
and cortical blindness,[170] other authors include dorsal midbrain syndrome, isolated 
bilateral ptosis, papillitis, cerebral hemorrhage, painful cervical radiculopathy, progressive 
swelling of arm, paraplegia due to intramedullary cyst, third ventricular cyst, dystonia and 
nominal aphasia masquerading as transient ischaemic attacks, [171] and an associated 
pachymeningitis of the cervical spinal cord.[172]  
3.1. Brainstem neurocysticercosis 
3.1.1. Midbrain, pons and medulla oblongata NCC 
In vertebrate anatomy the brainstem (or brain stem) is the posterior part of the brain, 
adjoining and structurally continuous with the spinal cord. The brain stem provides the 
main motor and sensory innervation to the face and neck via the cranial nerves. This is an 
extremely important part of the brain as the nerve connections of the motor and sensory 
systems from the main part of the brain to the rest of the body pass through the brain stem. 
This includes the corticospinal tract (motor), the posterior column-medial lemniscus 
pathway (fine touch, vibration sensation and proprioception) and the spinothalamic tract 
(pain, temperature, itch and crude touch). The brain stem also plays an important role in the 
regulation of cardiac and respiratory function. It also regulates the central nervous system, 
and is pivotal in maintaining consciousness and regulating the sleep cycle. The brain stem 
has many basic functions including heart rate, breathing, sleeping and eating. It is usually 
described as including the medulla oblongata (myelencephalon), pons (part of 
metencephalon), and midbrain (mesencephalon).Less frequently, parts of the diencephalon 
are included. 
Isolated brainstem involvement in patients who have neurocysticercosis is rare, usually, it 
occurs in association with disseminated forms of cysticercosis and some patients can present 
acute midbrain syndrome responding well to corticosteroids [173,178-180] although 
tapering of corticosteroids should be performed very slowly in such cases [174] good 
response to albendazol therapy [175, 177, 178,179] and spontaneous resolution have been 
reported. The importance of recognizing this entity allows to avoid unnecessary surgical 
intervention, empirical anti-tuberculous chemotherapy, [176] and to recommend a 
conservative approach to case management, including observation. [175] The segment of the 
brainstem most frequently affected by the larval stage of the T solium is the midbrain, 
followed by the pons and in some anecdotal cases the medulla oblongata. We will comment 
a little bit more about this presentation. 
3.1.2. Midbrain neurocysticercosis  
The midbrain or mesencephalon is a portion of the central nervous system associated with 
vision, hearing, motor control, sleep/wake, arousal (alertness), and temperature regulation. 
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Anatomically, it comprises the tectum (or corpora quadrigemina), tegmentum and the 
cerebral peduncles, as well as several nuclei and fasciculi. Caudally the mesencephalon 
adjoins the pons (metencephalon) and rostrally it adjoins the diencephalon (Thalamus, 
hypothalamus, etc.). The midbrain is located below the cerebral cortex, and above the 
hindbrain placing it near the center of the brain. The clinical features of the midbrain 
neurocysticercosis (MIDNCC) could be summarized as follows: 
1. Pretectal syndrome 
The pretectal area, or pretectum, is a midbrain structure composed of seven nuclei and 
comprises part of the subcortical visual system. Through reciprocal bilateral projections to 
the retina, it is primarily involved in mediating pupillary light reflex, the optokinetic reflex, 
the accommodation reflex, and temporary changes to the circadian rhythm. In addition to 
the pretectum's role in the visual system, the anterior pretectal nucleus has been found to 
mediate somatosensory and nociceptive information. Parinaud's Syndrome, also known as a 
dorsal midbrain syndrome (Pretectal syndrome) is a group of abnormalities of eye 
movement and pupil dysfunction. It is caused by lesions of the upper brain stem and is 
named for Henri Parinaud (1844–1905), considered to be the father of French 
ophthalmology. 
As before-mentioned, isolated brainstem involvement in patients who have 
neurocysticercosis is rare and symptoms and signs of MIDNCC can vary from one reported 
patient to another according to the exact location of T solium NCC. [174,175,181,182] 
The symptoms of NCC of the pretectal area are nonspecific, but abnormal pupils, vertical 
gaze limitation, disjunctive horizontal and vertical eye position, lid retraction, and 
convergence-retraction nystagmus can be seen.[181] 
2. Weber syndrome  
Superior alternating hemiplegia is usually a form of stroke characterized by the presence of 
an oculomotor nerve palsy and contralateral hemiparesis or hemiplegia but cases secondary 
to MIDNCC (acute onset right 3rd nerve palsy with left hemiplegia) has been reported. [176] 
3. Third cranial nerve palsy 
Oculomotor nerve palsy is an eye condition resulting from damage to the third cranial nerve or 
a branch thereof. As the name suggests, the oculomotor nerve supplies the majority of the 
muscles controlling eye movements. Thus, damage to this nerve will result in the affected 
individual being unable to move their eyes normally. In addition, the nerve also supplies the 
upper eyelid muscle (Levator palpebrae superioris) and the muscles responsible for pupil 
constriction (sphincter pupillae). The limitations of eye movements resulting from the condition 
are generally so severe that the affected individual is unable to maintain normal alignment of 
their eyes when looking straight ahead, leading to strabismus and, as a consequence, double 
vision (diplopia). In the chapter entitled: “Orbital cysticercosis.A challenger for neurologists, 
ophthalmologists, neuro-ophthalmologists, and general practitioner” more detailed information 
about extraocular muscle palsy due to cysticercosis is available. 
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Isolated third cranial nerve palsy is usually due to vascular causes like posterior 
communicating artery aneurysm and it is rare in NCC and is usually caused by 
supratentorial or sub-arachnoid lesions with accompanying hydrocephalus or meningitis 
however patients presenting third cranial nerve palsy caused by neurocysticercosis 
involving the midbrain has been reported. [174, 183]  
4. Claude's syndrome  
Claude's syndrome is a distinctive brainstem syndrome characterized by ipsilateral third 
cranial nerve palsy with contralateral hemiataxia and is due to an intrinsic or extrinsic lesion 
in the midbrain. The most common cause of Claude’s syndrome is ischemic stroke on the 
midbrain however one patient presenting Claude’s syndrome secondary to MIDNCC is 
reported. Therefore, if we encounter Claude's syndrome, we should consider 
neurocysticercosis infection as one of the etiologic factors [179] 
5. Superior divisional oculomotor nerve palsy 
Superior divisional oculomotor nerve palsy caused by intrinsic brain stem disease occurs 
rarely. The first case of midbrain neurocysticercosis presenting as isolated superior 
divisional paresis of the oculomotor nerve was communicated by Chotmongkol et al,. in 
2006. [177]  They reported a 25-year-old woman presented with acute onset of headache and 
ptosis-upgaze palsy of the right eye. This is an anecdotal case but serve to keep in mind  
MIDNCC for the differential diagnosis in similar cases. 
6. Sudden-onset ptosis [184] 
Sudden onset of ptosis secondary to MIDNCC was identified in 2008 and the first two children 
were informed to the medical literature by Singhi et al. [184] Recently Naphade et al., [180] 
reported the case of a 45-year-old woman who presented with acute onset of bilateral 
symmetrical ptosis with no other neurological deficit. Her imaging revealed a single cystic 
ring-enhancing lesion with perilesional oedema in the midbrain suggestive of NCC.  
3.1.3. Pontine neurocysticercosis 
The pons is a structure located on the brain stem, named after the Latin word for "bridge" or 
the 16th-century Italian anatomist and surgeon Costanzo Varolio (Pons Varolii). It is cranial 
to the medulla oblongata, caudal to the midbrain, and ventral to the cerebellum. In humans 
and other bipeds this means it is above the medulla, below the midbrain, and anterior to the 
cerebellum. This white matter includes tracts that conduct signals from the cerebrum down 
to the cerebellum and medulla, and tracts that carry the sensory signals up into the 
thalamus. The pons measures about 2.5 cm in length. Most of it appears as a broad anterior 
bulge rostral to the medulla. Posteriorly, it consists mainly of two pairs of thick stalks called 
cerebellar peduncles which connect the cerebellum to the pons and midbrain. The pons 
contains nuclei that relay signals from the forebrain to the cerebellum, along with nuclei that 
deal primarily with sleep, respiration, swallowing, bladder control, hearing, equilibrium, 
taste, eye movement, facial expressions, facial sensation, and posture. The pons is implicated 
in sleep paralysis, and also plays a role in generating dreams. 
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Clinical features of pontine neurocyticercosis (PNCC) also depends of different locations of 
the T solium at the pontine level such as: 
1. Internuclear ophthalmoplegia 
Internuclear ophthalmoplegia (INO) is a disorder of conjugate lateral gaze in which the 
affected eye shows impairment of adduction. When an attempt is made to gaze 
contralaterally (relative to the affected eye), the affected eye adducts minimally, if at all. The 
contralateral eye abducts, however with nystagmus. Additionally, the divergence of the 
eyes leads to horizontal diplopia. That is, if the right eye is affected the patient will "see 
double" when looking to the left, seeing two images side-by-side. Convergence is generally 
preserved. Clinical presentations of INO can be divided into: unilateral INO, bilateral INO, 
and one-and-a-half syndrome in a similar descending frequency. [185] Perhaps the more 
difficult clinical diagnosis to perform is the One-and-a-half syndrome (OAHS). It is a 
neurological disorder of the extra ocular movements characterized by conjugate horizontal 
gaze palsy in one direction and internuclear ophthalmoplegia (INO) in the other. The 
commonest cause of the syndrome is a vascular lesion on the basilar territory followed by 
demyelinating lesions of the brainstem usually affecting the paramedian pontine reticular 
formation unilaterally or due to lesions on the abducens nucleus on one side, with 
interruption of internuclear fibbers of the ipsilateral medial longitudinal fasciculus after it 
has crossed the midline from its side of origin in the contra lateral abducens nucleus causing 
failure of adduction of the ipsilateral eye. [186]  
In 2004, we proposed a new classification for OAHS based on our finding in patients with 
NCC and cerebrovascular diseases and we described the clinical features of One-and-a-half 
“plus” syndrome. We found patients with other combinations that can be called as: Five-
and-a-half syndrome (1 ½ + 4-throclear nerve), Seven-and-a-half syndrome (1 ½ + 6-
abducens) or Eleven-and-a-half syndrome (1 ½ + 7-facial nerve + 3-oculomotor nerve) due to 
racemose NCC, and midbrain lesions related to NCC. However we honestly considered at 
that time and even today that a generation of novel arithmetic combinations will bring more 
confusion than clarity to this problem and will increase unnecessarily the long list of 
different names of neuro-ophthalmological disorders, therefore we concluded that adding 
the term "plus" was good enough to distinguish these conditions from the typical OAHS. 
[186] Five years later Ranjith et al [178] studied an 18-year-old male presented with a history 
of sudden-onset diplopia of 1-week duration and blurring of vision. He had no history of 
headache, fever, seizures, walking difficulty, previous head injury, diabetes or hypertension. 
There was no history of a similar episode in the past. Diplopia was found to increase while 
looking to the left. Findings from general examination were normal. The left eye was 
deviated outward, and the right eye was central in primary gaze. There was a weakness of 
adduction in the left eye and paralysis of all conjugate horizontal eye movements in the 
right eye. The left eye also showed nystagmus while the patient attempted left lateral gaze. 
Vertical eye movements were normal, and no ocular bobbing was observed. There was no 
long tract sign, and the cerebellar system was normal. They confirmed OAHS secondary to 
PNCC. 
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2. Simulating cystic tumor 
Characterized by focal neurological signs and clinical manifestation of intracranial 
hypertension including abducens palsy among other features. Cases have been reported 
[187]  
3. Hemifacial spasm 
Ipsilateral hemifacial spasm and associated bladder incontinence and confusional state 
secondary to PNCC has been reported [173] 
4. Isolated facial myokymia 
In patients presenting a history of continuous rippling and quivering movements of their 
hemiface suggestive of myokymia, a diagnosis of PNCC should be taking into account. The 
first well documented patient was reported in the medical literature by Bhatia et al in 2008 
[188] 
3.1.4. Medulla oblongata neurocysticercosis 
The medulla oblongata is the lower half of the brainstem. In discussions of neurology and 
similar contexts where no ambiguity will result, it is often referred to as simply the medulla. 
The medulla contains the cardiac, respiratory, vomiting and vasomotor centers and deals 
with autonomic, involuntary functions, such as breathing, heart rate and blood pressure. 
The medulla neurocysticercosis (MENCC) is an extremely rare presentation of NCC and the 
main affected area is the lateral aspect of the medulla leading to: Lateral medullary 
syndrome (also called Wallenberg syndrome and posterior inferior cerebellar artery 
syndrome) which is characterized by sensory deficits affecting the trunk and extremities on 
the opposite side of the MEDNCC and sensory deficits affecting the face and cranial nerves 
on the same side of the lesion. Specifically, there is a loss of pain and temperature sensation 
on the contralateral (opposite) side of the body due to damage of the spinothalamic tract and 
ipsilateral side of the face including an absence of corneal reflex due to lesion of the spinal 
trigeminal nucleus. Clinical symptoms include ataxia secondary to damage of the inferior 
cerebellar peduncle, facial pain, vertigo and nystagmus due to lesion of Deiters' nucleus and 
the inferior vestibular nucleus, and possibly palatal myoclonus may be observed due to 
disruption of the central tegmental tract. Damage to the hypothalamospinal fibers disrupts 
sympathetic nervous system relay and gives symptoms analogous to Horner syndrome. If 
patients also start vomiting then the extension of the damage toward the area postrema 
(dorsal vagal complex) should be considered. Remember that the area postrema is located 
outside of the blood–brain barrier and connects to the nucleus of the solitary tract and other 
autonomic control centers in the brainstem, which may serve as the beginning of the 
pathway triggering vomiting in response to various emetic inputs. The MEDNCC causing 
Wallenber syndrome has been communicated by Garg in 1999. [189] 
Other uncommon presentations of NCC may include: Bilateral trigeminal neuralgia 
secondary to racemous cysticercus of the cerebellopontine angle, [190] and bradycardia due 
to right cerebellar peduncle neurocysticercosis, [191]  
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3.1.5. Insula lobe neurocysticercosis 
In each hemisphere of the mammalian brain the insular cortex (often called insula, insulary 
cortex, Island of Reil or the insular lobe) is a portion of the cerebral cortex folded deep within 
the lateral sulcus between the temporal lobe and the frontal lobe. The insula is believed to be 
involved in consciousness and play a role in diverse functions usually linked to emotion or 
the regulation of the body's homeostasis. These functions include perception, motor control, 
self-awareness, cognitive functioning, and interpersonal experience. In relation to these it is 
involved in psychopathology.  
The insular cortex is divided into two parts: the larger anterior insula and the smaller 
posterior insula in which more than a dozen field areas have been identified. The cortical 
area overlying the insula towards the lateral surface of the brain is the operculum (meaning 
"lid"). The Operculum, derived from Latin, meaning "little lid", refers to the cerebral cortex 
that covers the insula and is formed from parts of the enclosing frontal, temporal and 
parietal lobes. Operculum-insular cortex plays a role in the processing of nociceptive input. 
It has been convincingly established, over the past decade, that the human insular cortices 
are involved in processing both body feelings (such as pain) and feelings of emotion. 
Recently, however, an interpretation of this finding has emerged suggesting that the insular 
cortices are the necessary and sufficient platform for human feelings, in effect, the sole 
neural source of feeling experiences. [192] 
Between the years 1999 and 2005 we studied a series of patients with NCC located in the 
lobe of the insula (INCC) confirmed by imagenology. All came from the epilepsy/NCC clinic 
and the neurology clinic of the Mthatha Hospital Complex. This study was designed for the 
screening of symptoms and clinical signs such as: dysphagia, dysarthria, attention deficit 
disorders, cardiovascular problems, and epileptic seizures.  
All the patients underwent a CT scan of the brain and/or MRI, an ELISA test for the 
determination of antigens and antibodies of CC in serum and an electrocardiogram. For all 
patients a digital interictal EEG was performed based on, the 10-20 system and each study 
lasted about 20 minutes looking for focal or generalized alterations of the background 
rhythm or paroxysmal activity. 
It was considered that the patient had difficulty swallowing liquids when they were 
choking or coughing after swallowing five cubic centimeters of water. In the first six 
month period of this study we explored the ability of the patients to differentiate between 
expressions of fear or disgust in photos or drawings that we show them for that purpose. 
Unfortunately many patients did not have the capacity to differentiate an expression of 
joy, fear or sadness; however we erroneously believe that this test did not work and it was 
eliminated from this study. In this research, special attention was given in the exclusion of 
patients with a history of other neurological diseases in addition to epilepsy, metabolic 
diseases of any type of ischemic heart disease or diseases causing difficulty in swallowing, 
the syndromes of Jervell-Lang -Nielsen, Romano-Ward and other causes of prolongation 
of the QT Segment. 
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Two patients died and in the postmortem studies T solium cystic lesions were confirmed in 
the insular cortex. (See figure 7) The problems most frequently encountered were functional 
dysphagia, the visual and somato-sensory inattention, ECG alterations such as ST-segment 
depression greater than 0.1 millivolts by more than 80 milliseconds and elongation of the QT 
Segment (greater than 0.44 seconds). 
In our series, disturbances of the language due to the NCC are very uncommon excepting 
some patients presenting ischemic stroke due to cysticercotic /HIV/AIDS vasculitis. It is 
even rare in patients presenting T solium cystic lesions in the motor or sensory language 
cortical regions. In patients with lesions of the insula with involvement of the superior 
temporal gyrus and the inferior parietal region, conductive afasias have been reported, [193] 
but we have not been able to identify any single patient with isolated disorders of the 
speech or spoken languages without stroke.  
The insula of the right cerebral hemisphere may play an important role in the autonomic 
control of the heart and the electrocardiographic abnormalities of the heart are often transient, 
but represent a diagnostic problem sometimes indistinguishable from a myocardial infarction. 
Some alterations of the T waves may be suggestive of cardiac pathology, but are not specific so 
it is important to consider this situation to avoid inappropriate treatment. 
In the year 2004, Colivichi et al. [194] designed a study to establish the relationship between 
the vascular ischemic brain damage at the level of the right insular lobe and cardiac 
arrhythmias and they concluded that this area of the brain exerts a controlling function of 
the visceral autonomic activity on the heart with prognostic implications. However, the 
cardiac signs found in our series such as: asystole and bradycardia may also be suggestive of 
cardiac dysfunction secondary to left insula as has previously been reported in patients with 
temporal lobe epilepsy [195-198] and confirmed in 2009 by Koseoglu et al.[199] The epileptic 
activity spreads through the limbic system with the involvement of the amygdala, 
hypothalamus, and thalamus. These, in turn stimulate the autonomic system at medullar 
level including the nucleus tractus solitarius and the nucleus ambiguous which generate 
sympathetic and parasympathetic discharges.[200]  
In our first study the ictal manifestations found were: laryngeal constriction, oppression of 
the chest, paresthesia of peri-oral region, the feeling of suspension or floating and some taste 
disorders. The characteristics of the epileptic seizures in these patients could not be defined 
convincingly at that time, therefore few years later, the realization of a methodological 
design addressed primarily to achieve that goal was made. However as noted earlier in this 
study could not arrive at confident conclusions. Later we concluded that the INCC is 
characterized by a functional dysphagia, ECG alterations such as: ST-segment depression 
and especially a prolongation of the QT segment, atypical epileptic seizures, a slight spastic 
dysarthria, sensory lapses and cardiovascular disorders. [7, 15]  
Finally, we would like to highlight that even when the clinical features of the lesions in the 
insula are known mainly from neurophysiological studies and by electrical stimulation of 
the insular cortex, our clinical findings were not previously reported in the international 
medical literature although some of them were confirmed later by other authors. [201-203] 
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Figure 7. Right insular lobe with T solium cysticercosis in different stages. Unfortunately some cyst was 
damaged during disserting procedures. 
In brief: patient with INCC may submit a functional dysphagia with visual and somato-
sensory inattention, signs of neurogenic heart and, ECG alterations such as ST-segment 
depression greater than 0.1 millivolts for longer than 80 milliseconds and elongation of the 
QT segment (greater than 0.44 seconds) and that special attention should be given to this 
mode of presentation by the serious complications that can be involved, including death. 
The clinical features of epileptic seizures secondary to NCCI are characterized by 
paroxysmal feeling of laryngeal constriction, the functional dysphagia, and peribucal 
paresthesia. We must insist on the patient’s interview about these symptoms if there is 
evidence of INCC in imagenology. Frequently, neither the patient nor the family or friends 
give importance to these symptoms and the situation is even worse when the patient is 
assisted by other doctor, another diagnosis is made and do not to pay too much attention is 
suggested especially if the seizures are sporadic and apparently banal. The diagnosis is 
based on the clinical confirmation of these manifestations as the conventional EEG with 
surface electrode is normal. [7,15] 
3.1.6. Middle fossa neurocysticercosis 
Apart from subarachnoid NCC, T solium can also affect directly or indirectly midline 
anatomical structures such as: optic quiasm, hypothalamus, pituitary gland, and sella 
turcica. 
3.1.7. Optic quiasm NCC 
The optic chiasm (OCh) is the part of the brain where the optic nerves partially cross. 
Several important structures are located adjacent to the OCh. The supraclinoid branches of 
the internal carotid artery flank the OCh. The cavernous sinuses are lateral and inferior to 
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the OCh. The frontal lobe of the brain lies above. The pituitary gland sits below in the sella 
turcica. The sella turcica is bounded in front by the tuberculum sellae and behind of the 
dorsum sellae. Behind the chiasm lies the floor of the third ventricle. Chiasmal syndrome is 
the medical term used to describe the various signs and symptoms that are associated with 
lesions of the OCh, manifesting as various types of blindness or impairment in the sufferer's 
visual field according on the location of the lesions along the optic nerve.  
Optic NCC has been well described in the past and all interested readers can find more 
information in the chapter entitled: “Orbital cysticercosis. A challenger for neurologists, 
ophthalmologists, neuro-ophthalmologists, and general practtioners” in this book. However 
optic chiasm NCC (OChNCC) caused by intra-chiasmatic cysticercosis has not been reported 
up to date. It’s known that the clinical features of the OCh are caused by inflammatory 
processes secondary to cysticercotic vasculitis [204] or by released pro-inflammatory elements 
when close by cysticerci are dying. Neurocysticercosis may cause bitemporal hemianopsia due 
to chiasmatic compression secondary to obstructive hydrocephalus. [205] 
3.1.8. Intra-Sellar turcica neurocysticercosis 
The sella turcica is a midline depression in the sphenoid bone which contains the anterior 
and posterior lobes of the pituitary gland and the distal portion of the pituitary stalk. It is 
covered by a dural reflection, the diaphragm sellae. Above this lies the suprasellar cistern, 
which contains the supraclinoid carotid arteries and the optic tract, OCh, and nerves, and 
through which travels the pituitary stalk, Lateral to the sella turcica are the cavernous 
sinuses containing the carotid arteries, cranial nerves III, IV, and VI, and the first two 
divisions of the fifth cranial nerve. Anteriorly, the sella turcica is bound by the tuberculum 
sellae and anterolaterally by the anterior clinoid processes, Anteroinferiorly, the foramen 
rotundum conducts the maxillary branch of cranial nerve V. Posteriorly, there are the 
smaller posterior clinoid processes, the dorsum sellae, and the interpeduncular cistern 
containing cranial nerves III and IV. Inferiorly, the sella turcica has a thin floor of cortical 
bone, below which lies the air-containing sphenoid sinus. The sinus is extremely variable in 
size. Adjacent to the posteroinferior aspect of the cavernous sinus lies a Meckel's cave, 
containing the gasserian ganglion. Immediately below and lateral to the gasserian ganglion, 
the third branch of the fifth cranial nerve exits through the foramen ovale. 
In 1915, Kufs described a woman in whom destruction of the pituitary by one of multiple 
basilar cysts was found at autopsy. The diagnosis was not suspected antemortem, and the 
patient had findings that may have been related to pituitary insufficiency. [206] In 1955, 
panhypopituitarism was diagnosed by Dickinson [207] in a British soldier who had served 
in India and developed epilepsy with X-ray evidence of cysticerci in the legs and a distorted 
pituitary phase CT scan of the brain was not available at that time. The case reported by 
Briceflo et al. (1961) was one of 97 cases of cysticercosis found among 2 ,767 routine 
autopsies over a 6-year period in a large Mexican hospital. Clinical data were not presented, 
and the authors did not record whether the patient had other lesions elsewhere in the CNS. 
[209] A fourth report describes a patient with cysticercosis masquerading as a pituitary 
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tumor, but this probably represented enlargement and an erosion of the sella secondary to 
increased intra cranial pressure. [210] Therefore the fourth well documented patient  with 
sella turcica neurocysticercosis (STNCC) was studied by Prosser et al in 1978. They reported  
a 42-year-old woman from El Salvador presented with arthralgias and headache. She was 
found to have an enlarged sella with an intrasellar mass. Transsphenoidal exploration of the 
sella revealed a cysticercus, the cyst was successfully removed and normal pituitary 
function was retained. These authors recommend that cysticercosis be considered in the 
differential diagnosis of any patient from an endemic area who presents with a mass lesion 
anywhere in the CNS, including intrasellar masses. [210] Few years later other authors 
reported cases presenting disturbances in both visual acuity and visual fields and other 
considerations were made. [211,212] 
As a general rule, for patients from endemic areas presenting chiasmatic syndrome and 
hormonal disturbances to rule out STNCC is mandatory. Other authors have similar 
opinions. [210, 213-216] 
Although NCC damages sellar structures with direct compression by large cysts, extension 
through the basal cisterns and third ventricle with focal arachnoiditis can result as an 
inflammatory response. Taking into consideration that the sellar region and the basal cisterns 
contain many vascular and CNS structures that are separated by only a few millimeters 
increasing the possibility that different pathologic entities could affect them simultaneously 
then analysis of imaging findings and knowledge of the varied clinical presentations of NCC 
are important to detect cases of sellar involvement in patients with unexplained visual loss or 
atypical cystic lesions in the sella, especially in endemic countries. [213] As in other locations in 
the brain, the parasite can affect the sellar structures through diverse mechanisms, ranging 
from direct or indirect invasion to a severe local inflammatory response [217-218] Although 
direct invasion of the sella turcica by the NCC vesicle affecting the hypophysis is the most 
commonly described form in the literature [206-212] and is often confused with the most 
common tumors of the area (eg, cystic adenoma and craniopharyngioma). The absence of 
clinical suspicion of STNCC usually results in surgical treatment of the lesions and 
postoperative diagnosis of the NCC with variable clinical results. [213] 
A 7-year-old child presented with polyuria and polydipsia for 1 year due to a small cystic 
lesion in the proximal pituitary stalk was also reported in the medical literature. [214]  And 
three patients presenting hypopituitarism secondary to the NCC have been reported as well. 
[216] 
3.1.9. Hypothalamic neurocysticercosis 
The hypothalamus is a portion of the brain that contains a number of small nuclei with a 
variety of functions. One of the most important functions of the hypothalamus is to link the 
nervous system to the endocrine system via the pituitary gland (hypophysis). The 
hypothalamus is located below the thalamus, just above the brain stem. In the terminology 
of neuroanatomy, it forms the ventral part of the diencephalon. All vertebrate brains contain 
a hypothalamus. In humans, it is roughly the size of an almond. 
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The hypothalamus is responsible for certain metabolic processes and other activities of the 
autonomic nervous system. It synthesizes and secretes certain neurohormones, often called 
hypothalamic-releasing hormones, and these in turn stimulate or inhibit the secretion of 
pituitary hormones. The hypothalamus controls body temperature, hunger, thirst, fatigue, 
sleep, and circadian cycles. In mammals, the axons of magnocellular neurosecretory cells of 
the paraventricular nucleus and the supraoptic nucleus, which contain oxytocin and 
vasopressin (also called antidiuretic hormone), comprise the posterior pituitary. 
Parvocellular neurons of the paraventricular nucleus contain neurons that release 
corticotropin-releasing hormone and other hormones into the hypophyseal portal system 
where these hormones diffuse to the anterior pituitary. 
The hypothalamus is thus richly connected to many parts of the central nervous system, 
including the brainstem reticular formation and autonomic zones, the limbic forebrain 
(particularly the amygdala, septum, diagonal band of Broca, and the olfactory bulbs, and the 
cerebral cortex). The hypothalamic-pituitary-adrenal axis (HPA or HTPA axis), also known 
as the limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) and, occasionally, as the 
hypothalamus-pituitary-adrenal-gonadotropic axis, is a complex set of direct influences and 
feedback interactions among the hypothalamus, the pituitary gland (a pea-shaped structure 
located below the hypothalamus), and the adrenal glands. 
Hypothalamic neurocysticercosis (HTNCC) is another extremelly uncommon presentation 
of NCC and the most common clinical features of best documented patient are characterized 
by: obesity, galactorrhea and central diabetes insipidus (polyuria without solute diuresis), 
and panhypopituitarism due to an associated pituitary gland involvement can also be 
present.[207,217, 219-222, 224] It has been established that intracranial hypertension "per se" 
does not generate changes in the hypothalamopituitary axis function. [219]  
At a Uberaba Teaching Hospital in Brazil, a total of  1.596 autopsies performed between 1974 
and 1997 were studied. The study found a diagnosis of cysticercosis in 53 autopsies (3.3%) 
and in two obese patients with NCC the lesions were located in the ventromedial nucleus of 
the hypothalamus. [220] 
Other authors also divided the unusual manifestations of neurocysticercosis into: 
intraventricular, subarachnoid, spinal, orbital, intraparenchymatous, and reactivation of 
previously calcified lesions and they reported frequencies of  15.69%  of intraventricular 
presentations, subarachnoid: 11.63%; spinal: 3.49%; orbital: 0.58% and reactivated lesion: 
0.58% and the frequencies for association of intraventricular and intraparenchymatous: 
6.98%; association of subarachnoid and intraparenchymatous: 3.49;  and association of 
subarachnoid and intraventricular: 2.32%. [225] but they did not include other presentations 
already mentioned in this chapter. 
3.1.10. Solitary cysticercus granuloma 
The solitary cysticercus granuloma (SCG) is considered the most frequent type of NCC in 
India and many other Southeast Asian countries and these lesions are the most frequent 
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neuroimaging abnormality seen as: less than 20 mm ring-enhancing  lesion in patients with 
new-onset epilepsy. [223] However, in our region SCG is not the most frequent presentation 
of  NCC and compared with the prevalence of multiple active and the calcified 
intraparenchymal NCC  which is highest,  SCG is relatively uncommon probable related to 
unknown factors. 
3.1.11. Sinus thrombosis 
Only one patient presenting lateral sinus thrombosis secondary to NCC has been reported in 
the medical literature up to date. [226] 
4. Extracraneal cysticercosis 
Taenia solium cysticercosis can invade almost all extracraneal anatomical structures in the 
head excepting skin, nasal cavity, paranasal sinus, bone tissue and the periostium. 
When a temporalis muscle is involved, clinical presentation can be a temporal headache. 
Two woman who complained of subacute onset of left temporal pain and another 
complaining headache due to cysticercosis of the temporalis muscle have been reported. 
[227, 228] 
4.1. Ocular cysticercosis 
Ocular cysts are mostly vitreous or may be found in subretinal locations. Cysts can impair 
vision by floating in the eye and can lead to blindness by causing retinal detachment. 
Visualization of cysts via fundoscopy may be diagnostic of the disease.  
We dedicated a complete article for this issue and interested readers can find detailed  
information in the chapter entitled: “Orbital Cysticercosis. A challenger for neurologists, 
ophthalmologists, neurophthalmologists, and general practitioners”  
4.2. Facial cysticercosis 
We found facial cysticercosis in a patient presenting disseminate subcutaneous and 
muscular cysticercosis with cardiac involvement and NCC. [10] A cystic lesion on the right 
cheek and in the maxillofacial region have been also reported. [229, 230] A photo of patient 
showing a nodular lesion in the left hemiface at the zigomatic arch level that was removed 
by surgical procedures and histological examination confirmed T solium cysticercosis  can 
be seen in a previous chapter. 
4.3. Buco-lingua-pharyngeal cysticercosis 
4.3.1. Oral cysticercosis 
As other before-cited locations of cysticercosis this one, is also extremely uncommon. 
Patients presenting lesion in the lips, [231, 232] oral cavity, [233] oral mucosa, [232] and in 
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the gums [232] due to cysticercosis have been well documented. In all cases clinical 
manifestations are related to the size of the nodule lesion and good response to antiparasitic 
medication is the rule. 
Cysticercus in the tongue can be present up to 50% in porcine cysticercosis. However in 
human beings only anecdotal cases have been reported. [232, 234] 
4.4. Parotid gland cysticercosis 
Involvement of the parotid gland is manifest by a mass effect, masquerading as a salivary 
gland neoplasm or mild swelling with occasional aching sensation and headache, and 
features resembling acute parotitis [235-238] Parotid gland cysticercosis can be associated 
with NCC [237] or presenting as a solitary extracranial cysticercosis of the parotid gland. 
[238] In solitary lesions final diagnosis is based on fine needle aspiration cytology and 
immunological investigations and in patients with an associated NCC antigen/antibody 
tests for T solium cysticercosis can be useful. 
4.5. Neck cysticercosis 
Subcutaneous cysticercosis in the neck is usually part of the disseminated cysticercosis and 
it does not constitute an independent clinical entity by itself because its clinical features are 
similar to another subcutaneous location. [10] We studied one patient with this condition 
who is cited in the chapter entitled: “Orbital cysticercosis. A challenger for a neurologist, 
ophthalmologist, neurophthalmologists, and general practitioners”. Other uncommon 
presentations of cysticercosis around the neck are: thyroid cysticercosis (one patient is from 
our region), [239, 240] cricothyroid muscle cysticercosis, [241] pharyngeal cysticercosis, first 
described in South Africa, [242] submandibular lymphadenopathy cysticercosis in a 7-y-old 
girl presented with seizures and a right submandibular lymph node enlargement confirmed 
by fine needle aspiration cytology [243] and cervical lymphadenopathy cysticercosis [244] 
cysticercosis of submandibular duct [245] and isolated cysticercosis of the 
sternocleidomastoid [246] were also reported. 
5. Truncal cysticercosis 
5.1. Thoracic cysticercosis 
The thoracic cavity (or chest cavity) is the chamber of the human body (and other animal 
bodies) that is protected by the thoracic wall (thoracic cage and associated skin, muscle, and 
fascia) which can be infected by isolated T solium cysticercosis or disseminated cysticercosis 
as it has been reported in South African patients. [10, 240, 242, 247, 251 ] and others. [241, 
252-255] Anatomical structures within the thoracic cavity include: structures of the 
cardiovascular system, including the heart where cardiac cysticercosis can be seen. 
[10,247,248, 256-267] Parasitic diseases may involve various anatomic structures of the heart 
which can be manifested clinically as myocarditis, cardiomyopathies, pericarditis, or 
pulmonary hypertension in many resource-constrained settings. [263] Other structures are: 
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great vessels and the trachea but up to date, tracheal cysticercosis is seen only in porcine 
cysticercosis. [265] Esophageal cysticercosis has not been described; T solium thymic 
cysticercosis has not been reported as yet. In the other hand; vagus nerves, the paired 
sympathetic chains, lymphatic and the thoracic duct cysticercosis have not been well 
documented in the medical literature neither. Finally we would like to emphasize that 
pericardial cysticercosis is also extremely uncommon and has been mentioned in the 
international medical literature occasionally. [264,266] Other intra-thoracic anatomical 
structures are: lungs where pulmonary cysticercosis has been communicated. [240, 249, 250] 
Pulmonary infiltration with eosinophilia is a disease entity characterized by lung disease 
and eosinophilia its commonest causes  are tuberculosis, parasitic infestations, malignancy 
and connective tissue disorders. The first report about pleural effusion and subcutaneous 
cysticercosis in a 2 year old child is made by Salaria et al. in 2001. [268] In adults pleural 
effusion is the commonest presentation of pleural cysticercosis. [269, 270]  
5.2. Breast cysticercosis 
In women, the breasts overlay the pectoralis major muscles and usually extend from the 
level of the second rib to the level of the sixth rib in the front of the human rib cage; thus, the 
breasts cover much of the chest area and the chest walls. At the front of the chest, the breast 
tissue can extend from the clavicle (collarbone) to the middle of the sternum (breastbone). At 
the sides of the chest, the breast tissue can extend into the axilla (armpit), and can reach as 
far to the back as the latissimus dorsi muscle, extending from the lower back to the humerus 
bone (the longest bone of the upper arm). As a mammary gland, the breast is an 
homogeneous anatomic structure composed of layers of different types of tissue, among 
which predominate two types, adipose tissue and glandular tissue, which affects the 
lactation functions of the breasts. The blood supply to the breast is derived from 3 sources. 
The predominant supply of blood comes from the perforating branches of the internal 
mammary arteries, derived from the internal thoracic artery. The breast is supplied by the 
lateral thoracic and thoracoacromial arteries (branches of the axillary artery) as well as 
posterior intercostal arteries (branches of the thoracic aorta). Apart from breast pain, 
fibrocystic change, nipple discharge, tumor, bacterial and fungal infection and Paget’s 
disease; breast can also be infected by T solium cysticercosis. Some patients can present from 
mastalgia, hyperprolactinaemia [271] and painless mobile swelling (lump) in the breast [272] 
to no clinical manifestations. [273]  
In places where cysticercosis is frequent the before mentioned presentations are rare while 
in countries where cysticercosis had been exceedingly rare (i.e. Malaysia), with only one 
case of neurocysticercosis diagnosed during post-mortem in 1934 and another one 
diagnosed ante-mortem [274] any presentation is uncommon. 
5.3. Limbs cysticercosis 
Limbs cysticercosis may be isolated in the biceps brachii, deltoid, thigh, elbow, forearm, 
triceps, gluteal muscles [275-290] or as part of disseminated cysticercosis. [254, 291-296] The 
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clinical features depend on the location of the cyst, the cyst burden, and the host reaction 
but most of patients’ present painless, rubbery nodules around 2 cm in diameter, which do 
not carry any risk to the patient's health or can present pseudotumor, mass, 
pseudohypertrophy [295-298] and myalgias. [298] A positive diagnosis is established solely 
by incision and examination of the interior, where the parasite will be found. In the other 
hand , the role of ultrasonographic (USG) studies in the diagnosis of isolated soft tissue 
cysticercosis has been also confirmed. [295] The most common USG appearance is that of a 
cyst containing a scolex within and with surrounding abscess. The second most common 
appearance reported is that of a cyst containing a scolex within and with surrounding 
edema and the least common appearance is that of an irregular cyst with no scolex within 
and with surrounding edema. [295] Fine needle aspiration cytology [296] and even 
mitochondrial DNA analysis of extremely calcified cysts have demonstrated a good efficacy. 
[288] 
We found a good response to 100 mg/kg of praziquantel for a day [292] but in most patients 
albendazole is the medication of choice.  
Cysticercosis of the flexordigitorum profundus muscle producing flexion deformity of the 
fingers and cysticercosis of the tendon sheath of Tendoachilles have been reported. [300, 
301] 
Only one patient with cysticercosis presenting as an ulnar entrapment neuropathy due to a 
compressive mass in the flexor digitorum profundus has been reported. In this case 
magnetic resonance imaging suggested an inflammatory mass compressing the 
neurovascular bundle and the final diagnosis was confirmed by histologic examination. 
[302]  
 
Figure 8. Subcutaneous and intramuscular cysticercosis in the proximal region of the limbs 
predominantly 
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The most common location for soft tissue cysticercosis is in the skeletal muscles of the upper 
extremities (33. %) as we show in the next figure. , and the least common sites for isolated 
muscular cysticercosis are the back, buttock and cheek, which accounted for 3% each [287]. 
5.4. Monoarticular cysticercosis 
A joint is the location at which two or more bones make contact. They are constructed to 
allow movement (except for skull bones) and provide mechanical support to the body. A 
joint disorder is termed an arthropathy, and when involving inflammation of one or more 
joints the disorder is called: arthritis.  
Arthropathies are called polyarticular when involving many joints and monoarticular when 
involving only one single joint how can happens cysticercotic arthropathy. Fortunately it is 
another very rare condition. Kurrein and Vickers [303] reported a former regular soldier 
who had served in India before the Second World War. He was in 1953-1955 diagnosed as 
suffering from cysticercosis affecting the brain and spinal cord as well as the muscles. 
Twenty years later he was found to have sustained severe damage to the lumbar spine, 
eventually proved due to cysticercosis involving the bones, joints and psoas muscles. The 
problem of why and how the disease remained active 40 years after the initial exposure 
remains unexplained. Searches of the literature and enquiries from appropriate specialists 
have failed to produce any record of similar cases. Kumar e al., [304] studied a 62-years old 
man presented with complaints of pain in the large peripheral joints with limitation of 
movement for two months. Fine needle aspiration cytology of the nodular eruptions over 
joints demonstrated negatively birefringent needle shaped crystals while that of calcific 
lesion in soft tissue demonstrated cysticercus cellulose with scolex. However the majority of 
the researchers that we have consulted, agree that the diagnosis of joint cysticercosis in this 
patient demonstrates some doubts though cannot be rejected. 
The last report is made by Banu and Veen. [305] They studied an immunocompetent patient 
with disseminated cysticercosis who had involvement of the brain, subcutaneous tissues, 
lungs and skeletal muscles and presented with arthritis. This patient was otherwise 
asymptomatic in spite of the extensive involvement of multiple organs.  
6. Abdominopelvic cysticercosis 
Unfortunately we have come to the final part of this chapter faced severe space restrictions 
by what we have to reduce the content of each paragraph without sacrificing the quality of 
this chapter. 
The abdominopelvic cavity (APC) is the cavity of the human body that holds the bulk of the 
viscera including include the stomach, liver, gallbladder, spleen, pancreas, small intestine, 
kidneys, large intestine and reproductive organs, the urinary bladder, the pelvic colon, and 
the rectum. The APC is lined with a protective membrane termed the peritoneum. The 
kidneys are located in the abdominal cavity behind the peritoneum, in the retroperitoneum. 
The viscera are also covered, in the front, with a layer of peritoneum called the greater 
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omentum. The peritoneal cavity is a potential space between the parietal peritoneum and 
visceral peritoneum, that is, the two membranes that separate the organs in the abdominal 
cavity from the abdominal wall. The peritoneal cavity is the largest serosa sac in the body 
and secretes approximately 50 ml of fluid per day. This fluid acts as a lubricant and has anti-
inflammatory properties. 
Cysticercosis of the whole APC is another preventable faeco-oral transmitted T solium 
infection but for didactic purposes we will divide this topic in extra-abdominal and intra-
abdominal cysticercosis. 
6.1. Extra-abdominal cysticercosis 
In the abdominal, wall T solium cysticercosis can be found involving the anterior abdominal 
wall musculature [306-308] and  diagnosis can be done by sonography which can reveal a 
well-defined cystic lesion with an eccentric hyperechoic area within it and an eccentric, 
echogenic, pedunculated structure is seen within the cystic area of the lesion without 
calcification but inflammation and hypervascularity in the surrounding muscle also can be 
noted or can be confirmed by histopathology. Clinical manifestations include vague 
abdominal discomfort, tender or painless nodules. This presentation is more commonly seen 
in patients presenting disseminated cysticercosis [283, 292, 293, 296-298, 300-303] rather than 
isolated cysticercosis. [277-282, 286-289, 294] 
6.2. Intra-Abdominal cysticercosis 
In some anecdotal cases intra-abdominal cysticercosis is presenting as abdominal pain 
secondary to acute abdomen and reported cases have shown psoas muscle cysticercosis 
mimicking appendicitis [309] and mesenteric lymph node enlargement cysticercosis and 
associated appendicitis. [310] In this case is postulated that the larvae, after evagination in 
the small intestine, penetrated the mesenteric lymphatic, burrowing through the bowel wall, 
hence reaching the mesenteric lymph node. The before-cited case is the second case of 
isolated lymph node enlargement due to cysticercus infestation reported in the medical 
literature. 
One study made by Vianna et al., [311]  shows the frequency of cutaneous, muscular and 
visceral forms of cysticercosis in anatomopathological examinations and necropsies in the 
Federal District of Sao Paulo. In 64.911 protocols of anatomopathological examinations they 
found that 30 (0.05%) had the diagnosis of cysticercosis, 90% had cysticerci in the 
subcutaneous tissue, skeletal muscle or mucous membrane, 3.3% in lymph node and 6.7% in 
the central nervous system and two (7.4%) patients had cysticerci in the tongue. In 1520 
autopsy protocols reviewed, 25 (1.6%) autopsies with cysticercosis were found. 96% had 
cysticerci in the central nervous system, 8% in the heart, 8% in the skeletal muscle and 4% in 
the liver, either isolated or associated with cysticerci in other viscera. A total of 1122 people 
were also examined and the muscular cysticercosis was found in 42.4%, subcutaneous 
cysticercosis was present in 20.3% and the visceral cysticercosis was found in 3.4% of cases. 
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In this series patient with visceral cysticercosis, the cysts were localized in the heart, pleura, 
kidney and ovary without clinical manifestations of importance. 
6.3. Hepatic cysticercosis 
Cysticercosis of the liver by T solium or other tapeworms has been reported in the animal 
population since long time ago, [312] and the first human being patient with hepatic 
cysticercosis and clinical manifestations of liver damage and not associated to disseminate 
cysticercosis was reported in the international medical literature in 1995. [313] Up to date 
only four patients with hepatic cysticercosis have been well documented.[313-316] Solitary 
nodular lesion remains asymptomatic while multinodular lesions may manifest as acute or 
chronic hepatitis. The experience of the last report highlights the need to use high resolution 
ultrasonography of abdomen in patients with a high index of suspicion. [314] 
6.4. Pancreatic cysticercosis 
In one of the previous chapter we mentioned that DCC is a rare form of cysticercosis caused 
by dissemination of the larval form of the pork tapeworm T. solium and fewer than 50 cases 
have been reported worldwide. Involvement of the pancreas and spleen is even rarer. The 
best of our knowledge, the first patient presenting splenic and pancreatic involvement by 
cysticercosis leading to pancreatitis was born and grew up at the former rural Transkei in 
South Africa (where we are living) and was reported in 1987 by Scholtz and Mentis [240] the 
second case is reported by Jain et al., [317] and their patient presented a history of headache 
and vomiting and was found to have DCC with pulmonary, cardiac , pancreatic, intraocular, 
and extradural spinal canal involvement. The third (last one) patient presented a 
disseminated cysticercosis involving the brain, orbit, myocardium, muscle, subcutaneous 
tissues, spleen and pancreas but without clinical or biochemical evidence of pancreatitis due 
to infection by cysticerci. [318]  
6.5. Spleen and Kidney cysticercosis 
Cysticercosis of the spleen [318,319] and the kidneys [240, 311,319] have been reported in 
two and three occasions respectively, always as part of a disseminate cysticercosis. Clinical 
manifestations secondary to the spleen or renal damage caused by T solium are uncertain up 
to date. The first reported patient presenting renal cysticercosis came from our region. 
6.6. Pelvic cysticercosis 
Tenia solium cysticercosis can infect ovary and one anecdotal case has been without 
remarkable clinical manifestation has been reported. [311] 
6.7. Peritoneal cysticercosis 
There are several types of tapeworms such as T pisiformis, T hydatigena, T saginata, Taenia 
crassiceps and other parasites that can be found in the peritoneal cavity in several types of 
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animals, [320-324] but we are not aware of patients with peritoneal cysticercosis caused by T 
solium cysticercosis up to date.  
6.8. Adrenal gland cysticercosis 
The adrenal glands (also known as suprarenal glands) are endocrine glands that sit atop the 
kidneys; in humans, the right adrenal gland is triangular shaped, while the left adrenal 
gland is semilunar shaped. On CT scan, the average measurements for the right adrenal 
gland were: maximum width 0.61 cm (S.D. 0.2), the width of the medial limb 0.28 cm (S.D. 
0.08), and width of the lateral limb 0.28 cm (S.D. 0.06). The average measurements for the 
left adrenal gland were: maximum width 0.79 cm (S.D. 0.21), width of the medial limb 0.33 
cm (S.D. 0.09), and width of the lateral limb 0.30 cm (S.D. 0.10), [325] typically, they are less 
than 4 cm in length and less than 1 cm in width.  
Although variations of the blood supply to the adrenal glands are common, there are 
usually three arteries that supply each adrenal gland such as: the superior suprarenal artery, 
the middle suprarenal artery and the inferior suprarenal artery which represent three paths 
for cysticercosis to reach the adrenal glands. However due to the size of the adrenal glands 
the cysticerci cannot be accommodated there; therefore, the adrenal cistticercosis does not 
exist. Nevertheless, there are clinical manifestations of adrenal dysfunction related to T 
solium cysticercosis (even simulating pheocromocytoma) but secondary to NCC [326-328] 
when it is affecting the limbic-hypothalamic-pituitary-adrenal axis. 
7. Conclusion 
After an extensive review of the medical literature and from our database, we concluded 
that the uncommon clinical manifestations of cysticercosis are related to the immune status 
of the patient, the location and numbers or cisticercus in any organ or tissue able to 
accommodate cysticerci depending of its size, consistency of the tissue, and the 
characteristics of its blood supply. 
From the before-mentioned postulate is that there will never be cysticercosis in the skin, 
hair, nails, bones, and or organs, tissues and membranes with dimensions less than one 
centimeter. Outside of this rule, the cysticerci can be viewed in any organ of the human 
body causing direct or indirect damage with or without clinical manifestations. So any 
patient from an endemic area or not presenting clinical manifestation of unknown causes 
deserves an investigation in search of cysticercosis. 
Author details 
Humberto Foyaca Sibat and Lourdes de Fátima Ibañez Valdés 
Department of Neurology, Stroke Unit, Epilepsy and neurocysticercosis Clinic in Nelson Mandela 
Academic Hospital, Faculty of Health Sciences,  
Walter Sisulu University, Mthatha, South Africa 
 
Uncommon Clinical Manifestations of Cysticercosis 233 
Acknowledgement 
We wish to mention our eternal and deepest gratitude to Lorna María Foyaca García, Fátima 
Susana Foyaca Ibañez and Thabo Humberto Foyaca Ibañez for their delight support. 
Hereby, we acknowledge financial support from the Directorate of Research Development, 
Walter Sisulu University in South Africa, South African Medical Research Council and NRF. 
The founder had no role in study design, data collection and analysis, decision to publish, or 
preparation of the manuscript. 
8. References 
[1] Foyaca-Sibat H, Ibañez-Valdés LdeF.”Clinical trial of praziquantel and prednisone in 
rural patients with neurocysticercosis presenting recurrent epileptic attacks” The 
Internet Journal of Neurology 2002;2):41-50.  
http://www.ispub.com/journal/the_internet_journal_of_neurology/volume_1_number_
2_39/article/clinical_trial_of_praziquantel_and_prednisone_in_rural_patients_with_neu
rocysticercosis_presenting_with_recurrent_epileptic_attacks.html 
[2] Foyaca-Sibat H, Ibañez-Valdés LdeF.”Intraventricular neurocysticercosis in HIV 
patients. Should be approaching surgically?” II International Congress of Neurosurgery 
on Internet. 2003 Conference Proceeding http://www.neuroc.sld.cu/paper/TL-
neurocys.htm 
[3] Foyaca-Sibat H, Ibañez-Valdés LdeF “Intraventricular neurocysticercosis in HIV 
patients” The Internet Journal of Neurology 2003;2(1):23-31.  
http://www.ispub.com/journal/the_internet_journal_of_neurology/volume_2_number_
1_37/article/intraventricular_neurocysticercosis_in_hiv_positive_patients.html 
[4] Foyaca-Sibat H, Ibañez-Valdés LdeF.”Pseudoseizures and Epilepsy in 
neurocysticercosis” Electron J Biomed 2003;2(2):20-29.  
http://www.uninet.edu/reb/2003/n2/2foyaca.html 
[5] Foyaca-Sibat H, Ibañez-Valdés LdeF “Neurocysticercosis in HIV-positive patients” The 
Internet Journal of Infectious Diseases 2003:2(2):15-23.  
http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijn/current.xml 
[6] Ibañez-Valdés LdeF, Foyaca-Sibat H. Refractory epilepsy in neurocysticercosis. The 
Internet Journal of Neurology 2006;5(2):34-41.  
http://www.ispub.com/journal/the_internet_journal_of_neurology/volume_5_number_
2_19/article/refractory_epilepsy_in_neurocysticercosis.html 
[7] Foyaca-Sibat H. Ibañez-Valdés LdeF. Insular Neurocysticercosis: Our Finding and 
Review of the Medical Literature. The Internet Journal of Neurology 2006 vol 5  
Number 2.  
http://www.ispub.com/journal/the_internet_journal_of_neurology/volume_5_number_
2_19/article/insular_neurocysticercosis_our_findings_and_review_of_the_medical_liter
ature.html 
 Novel Aspects on Cysticercosis and Neurocysticercosis 234 
[8] Carabin H, Krecek RC, Cowan LD, Michael L, Foyaca-Sibat H, Nash T, Willingham AL 
“Estimation of the monetary burden of Taenia solium cysticercosis in the Eastern Cape, 
South Africa”. Trop. Med. Int. Health.( ISSN: 1360-2276). 2006;11: 906-916. 
[9] Foyaca-Sibat  H, Ibañez-Valdés LdeF : Occipital Lobe Syndrome Due To Giant 
Intraparenchymal Neurocysticercosis . The Internet Journal of Neurology. 2006 Volume 
5 Number 2.  
http://www.ispub.com/journal/the_internet_journal_of_neurology/volume_5_number_
2_19/article/occipital_lobe_syndrome_due_to_giant_intraparenchymal_neurocysticerco
sis.html 
[10] Foyaca-Sibat H, Ibañez-Valdés LdeF: “Generalized Cysticercosis With Cardiac 
Involvement”. The Internet Journal of Neurology.( ISSN: 1531-295X). 2007;7(2):6-11 
http://www.ispub.com/journal/the_internet_journal_of_neurology/volume_7_number_
2_5/article/generalized_cysticercosis_with_cardiac_involvement.html 
[11] Foyaca-Sibat H, Ibañez-Valdés LdeF: “Co-morbidity of Spinal Cord Neurocysticercosis 
And Tuberculosis In A HIV-Positive Patient”. The Internet Journal of Neurology. ( 
ISSN: 1531-295X). 2007;7(3):5-10  
http://www.ispub.com/journal/the_internet_journal_of_neurology/volume_7_number_
2_5/article/comorbidity_of_spinal_cord_neurocysticercosis_and_tuberculosis_in_a_hiv_
positive_patient.html 
[12] Foyaca-Sibat H Cowan LD, Carabin H, Serrano-Ocaña G, , Krecek RC,  Willingham A. 
“Accuracy of serological exam for the diagnosis of neurocysticercosis in outpatients 
with epilepsy, Eastern Cape Province, South Africa” PLOS Negleted 
Trop.Dis.Dec.2009;3(3):1-7. 
[13] Foyaca-Sibat H, Ibañez-Valdés LdeF & J. Moré-Rodríguez: Parasitic Zoonoses Of The 
Brain: Another Challenger?. The Internet Journal of Neurology. 2010 Volume 12 
Number 2  
http://www.ispub.com/journal/the_internet_journal_of_neurology/volume_12_number
_2_4/article/parasitic-zoonoses-of-the-brain-another-challenger.html 
[14] Humberto Foyaca-Sibat and Lourdes de Fátima Ibañez-Valdés (2011). Treatment of 
Epilepsy Secondary to Neurocysticercosis, Novel Treatment of Epilepsy, Humberto 
Foyaca-Sibat (Ed.), ISBN: 978-953-307-667-6, InTech,  Rijeka 
[15] Humberto Foyaca-Sibat and Lourdes de Fátima Ibañez Valdés (2011). Clinical Features 
of Epilepsy Secondary to Neurocysticercosis at the Insular Lobe, Novel Aspects on 
Epilepsy, Humberto Foyaca-Sibat (Ed.), ISBN: 978-953-307-678-2, InTech, Rijeka 
[16] Humberto Foyaca-Sibat (2011). Epilepsy Secondary to Parasitic Zoonoses of the Brain, 
Novel Aspects on Epilepsy, Humberto Foyaca-Sibat (Ed.), ISBN: 978-953-307-678-2, 
InTech,  Rijeka 
[17] Takayanagui OM, Jardim E. Clinical aspects of nerocysticercosis: analysis of 500 cases. 
Arq Neuropsiquiatr 1983; 41(1):50-63. 
[18] Takayanagui OM. Neurocysticercosis: I.Clinical and laboratory course of 151 cases. Arq 
Neuropsiquiatr 1990; 48(1):1-10. 
 
Uncommon Clinical Manifestations of Cysticercosis 235 
[19] Takayanagui OM, Leite JP. Neurocysticercosis. Rev Soc Bras Med Trop 2001;34(3):283-
290. 
[20] Sarti E. La taeniasis y cisticercosis en México (revisión bibliográfica). Salud Pública Mex 
1986; 28:556-563. 
[21] McComick G, Zec Chi-S, Heiden J. Cysticercosis Cerebri. Review of 127 cases. Arch 
Neurol 1982; 39:534-539.  
[22] Lopez-Hernández A, Garaizar C. Childhood Cerebral Cysticercosis: clinical features 
and computed tomographic findings in 98 Mexican children. Can J Neurol SC 
1982;9:401-407. 
[23] Kalra V, Paul VK, Marwah RK, Kichhar Gs, Bhargava S. Neurocysticercosis in 
childhood. Trans R Soc Trop Med Hyg 1987;81(3):371-373. 
[24] Scharf D. Neurocysticercosis. Two hundred thirty-eight cases from a California 
Hospital. Arch Neurol 1988; 45:777-780. 
[25] Sotelo J, Penagos P, Escobedo F, Del Brutto OH: Short course of albendazole therapy for 
neurocysticercosis. Arch Neurol 45:1130-1133, 1988.  
[26] Villa AM, Monteverde DA, Rodríguez W, Boero A, Sica RE. Neurocysticercosis in a 
hospital of the city of Buenos Aires: study of 11 cases. Arq Neuropsiquiatr 1993;51(3):336-
336. 
[27] Pitella JEH. Neuro schistosomiasis. Brain Pathol 1997;7:649-662. 
[28] Singh G. Neurocystycercosis in South-Central America and the Indian subcontinent. A 
comparative evaluation. Arq Neuropsiquatr 1997; 55(3A):349-356. 
[29] Singhi P, Ray M, Singhi S, Khandelwal N. Clinical spectrum of 500 children with 
neurocysticercosis and response to albendazole therapy. J Child Neurol 2000;15(4):207-
213. 
[30] Del Bruto OH, Santibáñez R, Rubio CA, Aguirre R, Diez E, Alarcón TA. Epilepsy due to 
neurocysticercosis: analysis of 203 patients. Neurology 1992; 42:389-392. 
[31] Del Brutto OH. Neurocysticercosis in children: clinical and radiological analysis and 
prognostic factor in 54 patients. Rev Neurol 1997; 25(147):1681-1484. 
[32] Del Brutto OH. Neurocysticercosis. Rev Neurol 1999; 29(5):4456-4466. 
[33] Del Bruto OH, Rajshekhar V, White AC Jr, Tsang VC, et al. Proposed diagnostic criteria 
for Neurocysticercosis. Neurology 2001; 57(2):177-183. 
[34] Rousseau MC, Guillotel B, Delmont J. Neurocysticercosis in the South-East of France 
1988-1998. Presse Med 1999;28(39):2141-2144. 
[35] Sanchez AL, Ljungstrom I, Medina MT. Diagnosis of human neurocysticercosis in 
endemic countries: clinical study in Honduras. Parasitol Int 1999;48(1):81-89. 
[36] Turkulov V, madle-Samardzija N, Canak G, Vukadinov J, Aleksic-Dordevic M. Clinical 
and diagnostic approaches to neurocysticercosis. Med Pregl 2001; 54(7-8):353-356. 
[37] Varma A, Gaur KJ. The clinical spectrum of Neurocysticercosis in the Uttraranchal 
region.Assoc Physicians India 2002;50:1398-1400. 
[38] Carpio A. Neurocysticercosis: an update. Lancet Infect Dis 2002;2:751-62. 
[39] Carpio A, Hauser WA. Prognosis for seizure recurrence in patients with newly 
diagnosed neurocysticercosis. Neurology 2002;59:1730–1734. 
 Novel Aspects on Cysticercosis and Neurocysticercosis 236 
[40] García HH, del Brutto OH. Taenia solium cysticercosis. Infect Dis Clin North Am 2000; 
14(1):97-119.  
[41] García HH, Evans CA, Nash TE, Takayanagui OM, White AC jret al., Current 
Consensus Guidelines for Treatment of Neurocysticercosis. Clin Microbiol Rev 2002; 
15(4)747-756. 
[42] White AC Jr. Neurocysticercosis: a major cause of neurological disease worldwide. Clin 
Infect Dis 1997;24:101-106. 
[43] White AC Jr. Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis 
and management. Ann Rev Med 2000;51:187-206. 
[44] Uddin J, Garcia HH, Gilman RH, Gonzalez AE, Friedland JS. Monocyte-astrocyte 
networks and the regulation of chemokine secretion in neurocysticercosis. J Immunol. 
2005 Sep 1;175(5):3273-3281. 
[45] Figueroa JJ, Davis LE, Magalhaes A. Extraparenchymal neurocysticercosis in 
Albuquerque, New México. J Neuroimaging. 2011;21(1):38–43. 
[46] Wallin M, Kurtzke J. Neurocysticercosis in the United States: review of an important 
emerging infection. Neurology 2004; 63: 1559-1564. 
[47] De Giorgio CM, Medina MT, Duron R, Zee C,. Escueta SP: Neurocysticercosis. Epilepsy 
Curr: 2004;4(3):107-111. 
[48] Bhigjee AI, Rosemberg S Optimizing therapy of seizures in patients with HIV and 
cysticercosis. NEUROLOGY 2006;67(Suppl 4):S19–S22. 
[49] Devinsky O. Patients with refractory seizures. N Engl J Med 1999; 340: 1.565-1.570. 
[50] Ramirez-Bermudez J, Higuera J, Sosa AL,et al. Is dementia reversible in patients with 
neurocysticercosis? J Neurol Neurosurg Psychiatry 2005; 76:1164-1166. 
[51] García HH,  Del Brutto OH,The Cysticercosis Working Group in Perú. Heavy 
nonencephalitic cerebral cysticercosis in tapeworm carriers. Neurology 1999; 53(7):1582. 
[52] Colli BO, Martelli N, Assirati JA Jr, et al. Surgical treatment of cysticercosis of the 
central nervous system. Neurosurgery Quarterly 1995:5;34-35. 
[53] Umredkar A, Singla N, Mohindra S, Bal A, Gupta SK. Giant intraparenchymal 
neurocysticercosis: Report of surgical aspects two cases. Neurol India 2009;57:800-802. 
[54] Agarwal PP, Gaikwad SB, Garg A, Gupta V, Mishra NK, Mehta VS. Giant 
intraparenchymal neurocysticercosis: Unusual MRI findings. Neurol India 2004;52:259-
260. 
[55] Prachi P. Agarwal, Shailesh B. Gaikwad, Ajay Garg, Vipul Gupta, N. K. Mishra, V. S. 
Mehta. Giant intraparenchymal neurocysticercosis: Unusual MRI Findings.Neurology 
India 2004;52(2):259-260. 
[56] Joubert J, Van As AD. Rapid and complete resolution of giant cysticercal cysts after 
administration of praziquantel. A report of 4 cases. S Afr Med J. 1990;77(3):154-157. 
[57] Berman JD, Beaver PC, Cheever AW, Quindlen EA. Cysticercus of 60-milliliter volume 
in human brain. Am J Trop Med Hyg 1981;30:616-619. 
[58] Castellanos F, Montes I, Porras LF, Peragallo E, Ampuero J, Rueda R. Quistes 
subarachnoideos gigantes por neurocisticercosis: a propósito de dos casos observados 
en un área rural de Extremadura. Rev Neurol 2000;30:433-435. 
 
Uncommon Clinical Manifestations of Cysticercosis 237 
[59] Ramesh VG, Parthiban A. Giant parenchymal cysticercosis with unusual imaging 
features. J Clin Neurosci 2008;15:1404-1406. 
[60] Proaño JV, Madrazo I, Avelar F, López-Félix B, Díaz G, Grijalva I. Medical treatment for 
neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med 
2001;345:879-85. 
[61] Agarwal PP, Gaikwad SB, Garg A, Gupta V, Mishra NK, Mehta VS. Giant 
intraparenchymal neurocysticercosis: unusual MRI findings. Neurol India. 2004 
Jun;52(2):259-260. 
[62] Umredkar A, Singla N, Mohindra S, Bal A, Gupta SK. Giant intraparenchymal 
neurocysticercosis: Report of surgical aspects two cases. Neurology India 
2009;57(6):800-802. 
[63] Takeshita I, Li HZ, Imamoto N, Cao YP, Gou CF, Liu DQ, Piao HZ, Fukui M.Unusual 
manifestation of cerebral cysticercosis. Fukuoka Igaku Zasshi. 1994;85(1):29-34. 
[64] Amaral L, Maschietto M, Maschietto R, Cury R, Ferreira NF, Mendonça R, et al. 
Unusual manifestations of neurocysticercosis in MR imaging : analysis of 172 cases. Arq 
Neuropsiquiatr. 2003;61:533–541. 
[65] Rocca U, Rosell A, Alvarez C. Surgical options in neurocysticercosis therapy. 
Neurosurg Q. 2005;15:5–13. 
[66] Bickerstaff Er, Small JM, Woolf AL. Cysticercosis of the posterior fossa. Brain 
1956;79:622-634. 
[67] Kla O. The clinical aspects and surgical treatment of racemose cysticercosis of the 
posterior cranial fossa. Vopr Neirokhir. 1961;25:30-34. 
[68] Lopes PG.Surgical treatment of cysticercosis of the posterior cranial fossa. Arq 
Neuropsiquiatr. 1971;29(1):76-92. 
[69] Filizzolo F, Nastasi G, Morello A. Cysticercosis of the posterior cranial fossa. Acta 
Neurol (Napoli). 1972;27(6):632-638. 
[70] Lushchenko AI. Diagnostic importance of laboratory and serological analysis of blood 
and cerebrospinal fluid in cysticercosis of the posterior cranial fossa. Lab Delo. 
1975;(7):409-411. 
[71] de Morais-Rêgo SF, Latuf NL. Cysticercosis of the fourth ventricle simulating a 
posterior fossa neoplasm in cerebral scintillography. Report of a case. Arq 
Neuropsiquiatr. 1978 Dec;36(4):371-374. 
[72] Keane JR.Cysticercosis: unusual neuro-ophthalmologic signs. J Clin Neuroophthalmol. 
1993 Sep;13(3):194-199. 
[73] Kim JH, Suh SI, Kim JH, Kwon TH, Chung HS. Giant neurocysticercosis cyst in the 
cerebellar hemisphere. Neurol Med Chir (Tokyo) 2006; 46:412-4.Neurol India. 2004 
Jun;52(2):259-60. 
[74] Cheepsattayakorn R, Tantachamroon T. Cysticercosis in the posterior cranial fossa. J 
Med Assoc Thai 1994;77:544-548. 
[75] Chang JH, Chang JW, Park YG, Kim TS.Cysticercosis of cerebellopontine cistern: 
differential diagnosis using MRI. Acta Neurochir (Wien). 2004 Apr;146(4):325-328. 
 Novel Aspects on Cysticercosis and Neurocysticercosis 238 
[76] Sang-Wook K, Moon-Kyu K, Sae-Moon O, Se-Hyuck P. Racemose Cysticercosis in the 
Cerebellar Hemisphere. J Korean Neurosurg Soc. 2010;48(1):59–61.  
[77] Zhu L, Shi Y, Pan X, Mo L, Weng X. Successful treatment of isolated cerebellar 
cysticercosis with albendazole. Chin Med J (Engl) 2003;116:637–638. 
[78] Kim JH, Suh SI, Kim JH, Kwon TH, Chung HS. Giant neurocysticercosis cyst in the 
cerebellar hemisphere. Neurol Med Chir (Tokyo) 2006;46:412–414. 
[79] Lalla RS, IyerVV, Asgaonkar DS. Neurocysticercosis as Anterior Inferior Cerebellar 
Artery syndrome. Bombay Hospital Journal. 2011;53(3): 643-645. 
[80] Zee CS, et al. MRI of intraventricular cysticercosis: Surgical implications. J Comput Assist 
Tomogr 1993;17(6):932-939. 
[81] Govindappa SS, et al. Improved detection of intraventricular cysticercal cyst with the 
use of three-dimensional constructive interference in steady state MR sequences. Am J 
Neuroradiol 2000;21(4):679- 684. 
[82] Sánchez L, Abad L, Lozano E, Maldonado G. Neurocisticercosis intraventricular. 
Presentación de un caso localizado en el tercer ventriculo. Radiologia. 2002;44:309-313.  
[83] Earnest MP, Reller LB, Filley CM, Grek AJ. Neurocysticercosis in the United States: 35 
cases and a review. Rev Infect Dis. 1987;9(5):961-979. 
[84] Kelesidis T, Tsiodras S. Extraparenchymal neurocysticercosis in the United States: a case 
report. Journal of Medical Case Reports 2011;5:359 . 
[85] Aguilar-Amat M, Martínez-Sánchez J, Medina P, et al. Síndrome de Bruns causado por 
neurocisticercosis intraventricular. Med Clin (Barc). 2011;137(1):45-46. 
[86] Carod-Artal FJ, et al. Neurocisticercosis intraparenquimatosa diseminada. Rev Neurol 
2000;30(5):498-499. 
[87] Cuetter AC, et al. Neurocisticercosis: Focus of intraventricular disease. Clinical Infectious 
Disease 1997;24:157-164. 
[88] Kramer J, et al. Transaqueductal migration of a neurocysticercus cyst. J Neurosurgery 
1992;77:956-958. 
[89] Neal JH. An endoscopic approach to cysticercosis cysts of the posterior third ventricle. 
Neurosurgery 1995;36(5):1040-1043. 
[90] Madrazo I, Proaño J. Tratamiento quirúrgico de la neurocisticercosis. En: Arriagada C, 
Nogales-Gaete J, Apta W, eds. Neurocisticercosis. Santiago: ARRYNOG 1997; 299-321. 
[91] García HH, Gonzalez AE, Evans CA, Gilman RH; Cysticercosis Working Group in Peru. 
Taenia solium cysticercosis. Lancet. 2003; 362: 547-556.  
[92] Proaño JV, Madrazo I, García L, García-Torres E, Correa D. Albendazole and 
praziquantel treatment in neurocysticercosis of the fourth ventricle. J Neurosurg 1997; 
87: 29-33. 
[93] Kelley R, Duong D, Locke G. Characteristics of Ventricular Shunt Malfunctions among 
patients with Neurocysticercosis. Neurosurgery  2002; 50:757-762. 
[94] Nogales-Gaete J, Arriagada RC, Rodrigo SR. Tratamiento de la neurocisticercosis: 
Revisión crítica. Rev Méd Chile 2006; 134: 789-796.  
[95] Ramírez-Ceballos JA, Marquéz RMC.Tratamiento endoscópico de la neurocisticercosis 
intraventricular. Rev Neurocir 2007;9(4):107-113. 
 
Uncommon Clinical Manifestations of Cysticercosis 239 
[96] Govindappa SS, et al. Improved detection of intraventricular cysticercal cyst with the 
use of three-dimensional constructive interference in steady state MR sequences. Am J 
Neuroradiol 2000;21(4):679- 684. 
[97] Sánchez L, Abad L, Lozano E, Maldonado G. Neurocisticercosis intraventricular. 
Presentación de un caso localizado en el tercer ventriculo. Radiologia. 2002;44:309-313.  
[98] Gallonel L, Bedushi A, D'Andrea F. Clinical aspects and therapeutic possibilities in 
cysticercosis of the fourth ventricle. Riv Patol Nerv Ment. 1957;78(3):1183-1186. 
[99] Patharangkura P, Jariya P, Tandhavadhana. Cysticercus racemosus in the fourth 
ventricle: report of two cases. Southeast Asian J Trop Med Public Health. 1980;11(4):532-
534. 
[100] Palmer J, Poulgrain P. Cysticercosis of the fourth ventricle: a report of two cases. Aust 
N Z J Surg. 1980 Feb;50(1):60-63. 
[101] Elliott EM, Fried RA. Cerebral cysticercosis of the fourth ventricle: a problem in 
primary care diagnosis. J Fam Pract. 1984;19(4):553-557. 
[102] Gupta RK, Jain VK, Kumar S, Gupta S, Haque I, Gujral RB. Unusual MRI appearances 
of cysticercus within the fourth ventricle. Neuroradiology. 1993;35(6):457-458. 
[103] Flisser A, Madrazo I. Evagination of Taenia solium in the fourth ventricle. N Engl J 
Med. 1996;335(10):753-754. 
[104] Govindappa SS, Narayanan JP, Krishnamoorthy VM, Shastry CH, Balasubramaniam 
A, Krishna SS. Improved detection of intraventricular cysticercal cysts with the use of 
three-dimensional constructive interference in steady state MR sequences. AJNR Am J 
Neuroradiol. 2000;21(4):679-684. 
[105] Savindra TL et al. Neurocysticercosis in Asia. The Internet Journal of Infectious 
Diseases 2002:1(2):21-23. 
[106] Singh S, Gibikote SV, Shyamkumar NK. Isolated fourth ventricular cysticercus cyst: 
MR imaging in 4 cases with short literature review. Neurol India. 2003;51(3):394-396. 
[107] Hortobágyi T, Alhakim A, Biedrzycki O, Djurovic V, Rawal J, Al-Sarraj S. Cysticercosis 
of the fourth ventricle causing sudden death: a case report and review of the literature. 
Pathol Oncol Res. 2009;15(1):143-146. 
[108] Prashantha DK, Netravathi M, Ravishankar S, Panda S, Pal PK. Reversible 
parkinsonism following ventriculoperitoneal shunt in a patient with obstructive 
hydrocephalus secondary to intraventricular neurocysticercosis. Clin Neurol 
Neurosurg. 2008;110(7):718-721. 
[109] Das A, Kesavadas C, Radhakrishnan VV, Nair NS. Teaching NeuroImages: Bruns 
syndrome caused by intraventricular neurocysticercosis. Neurology. 2009 Aug 
18;73(7):e34. 
[110] Roongpiboonsopit D, Shuangshoti S, Phanthumchinda K, Bhidayasiri R. Positional 
vomiting as the initial manifestation of Bruns syndrome due to cysticercosis in the 
fourth ventricle: a symptom reminiscent of an old disease. Eur Neurol. 2012;67(3):184-
185. 
 Novel Aspects on Cysticercosis and Neurocysticercosis 240 
[111] Hanak BW, Walcott BP, Codd PJ, Jones PS, Nahed BV, Butler WE, Asaad WF. Fourth 
ventricular neurocystercercosis presenting with acute hydrocephalus. J Clin Neurosci. 
2011;18(6):867-869.  
[112] Singh S, Gibikote SV, Shyamkumar NK. Isolated fourth ventricular cysticercus cyst: 
MR imaging in 4 cases with short literature review. Neurol India. 2003;51(3):394-396. 
[113] Costa CU, von Einsiedel HG, Disko R, Berthele A. Multicystic tumor in the fourth 
ventricle: consider neurocysticercosis. J Neurol. 2006;253(8):1092-1093.  
[114] Loyo M, Kleriga E, Estañol B. Fourth ventricular cysticercosis. Neurosurgery. 
1980;7(5):456-458. 
[115] Allcut DA, Coulthard A. Neurocysticercosis: regression of a fourth ventricular cyst 
with praziquantel. J Neurol Neurosurg Psychiatry. 1991;54(5):461-462. 
[116] Proaño JV, Madrazo I, García L, García-Torres E, Correa D.Albendazole and 
praziquantel treatment in neurocysticercosis of the fourth ventricle. J Neurosurg. 
1997;87(1):29-33. 
[117] Anandh B, Mohanty A, Sampath S, Praharaj SS, Kolluri S. Endoscopic approach to 
intraventricular cysticercal lesions. Minim Invasive Neurosurg. 2001;44(4):194-196. 
[118] Citow JS, Johnson JP, McBride DQ, Ammirati M. Imaging features and surgery-related 
outcomes in intraventricular neurocysticercosis. Neurosurg Focus. 2002 Jun 15;12(6):e6. 
[119] Zymberg ST, Paiva Neto MA, Gorgulho AA, Cavalheiro S. Endoscopic approach to 
fourth ventricle cysticercosis. Arq Neuropsiquiatr. 2003;61(2A):204-207. 
[120] Psarros TG, Coimbra C. Endoscopic third ventriculostomy for patients with 
hydrocephalus and fourth ventricular cysticercosis: a review of five cases. Minim 
Invasive Neurosurg. 2004;47(6):346-349. 
[121] Lapergue B, Hosseini H, Liance M, Rosso C, Decq P. Hydrocephalus and racemose 
cysticercosis: surgical alternative by endoscopic third ventriculostomy. Neurochirurgie. 
2005;51(5):481-488. 
[122] Husain M, Rastogi M, Jha DK, Husain N, Gupta RK.Endoscopic transaqueductal 
removal of fourth ventricular neurocysticercosis with an angiographic catheter. 
Neurosurgery. 2007;60(Suppl 2):249-253. 
[123] Husain M, Jha DK, Rastogi M, Husain N, Gupta RK. Neuro-endoscopic management 
of intraventricular neurocysticercosis (NCC). Acta Neurochir (Wien). 2007;149(4):341-
346. 
[124] Suri A, Goel RK, Ahmad FU, Vellimana AK, Sharma BS, Mahapatra AK. 
Transventricular, transaqueductal scope-in-scope endoscopic excision of fourth 
ventricular neurocysticercosis: a series of 13 cases and a review. J Neurosurg Pediatr. 
2008;1(1):35-39. 
[125] Cappabianca P, Cinalli G, Gangemi M, Brunori A, Cavallo LM, de Divitiis E, Decq P,  
et.al. Application of neuroendoscopy to intraventricular lesions. Neurosurgery. 2008; 
62(2):575-597. 
[126] Hanak BW, Walcott BP, Codd PJ, Jones PS, Nahed BV, Butler WE, Asaad WF. Fourth 
ventricular neurocystercercosis presenting with acute hydrocephalus. J Clin Neurosci. 
2011;18(6):867-869.  
 
Uncommon Clinical Manifestations of Cysticercosis 241 
[127] Wallin M, Kurtzke J. Neurocysticercosis in the United States: review of an important 
emerging infection. Neurology 2004; 63: 1559-1564. 
[128] Del Brutto O, Sotelo J. Neurocysticercosis Up date. Rev. Inf. Dis.1988;10(6):1075-1087. 
[129] Del Bruto OH, Rajshekhar V, White AC Jr, Tsang VC, et al. Proposed diagnostic 
criteria for Neurocysticercosis. Neurology 2001; 57(2):177-183. 
[130] Del Brutto O, Sotelo J. Albendazole therapy for subarachnoid and ventricular 
cysticerciosis. J Neurosurgery 1990; 62: 816-817. 
[131] Proaño JV, Madrazo I, Avelar F, López-Félix B, Díaz G, Grijalva I. Medical treatment 
for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med. 
2001;345:879–885. 
[132] García HH, Evans CA, Nash TE, Takayanagui OM, White AC jret al., Current 
Consensus Guidelines for Treatment of Neurocysticercosis. Clin Microbiol Rev 2002; 
15(4)747-756. 
[133] Cruz-Ultreras I, Cruz M. Tratamiento médico de la neurocisticercosis. En: Arriagada 
C, Nogales-Gaete J, Apta W, eds. Neurocisticercosis. Santiago: ARRYNOG 1997; 287-98. 
[134] Hatano S. Experience from a multicentre stroke registry: a preliminary report Bull 
World Health Organ. 1976;54:541–553.  
[135] Portenog RK, Abissi CJ, Lipton RB. Headache in acute cerebrovascular disease. Stroke 
1985;15:1009–1012.  
[136] Chodosh EH, Foulkes MA, Kase CS. Silent stroke in NINCDS stroke data bank. 
Neurology 1988;38: 1674–1679.  
[137] Cárdenas F, Quiroz H, Plancarte A. Taenia solium ocular cysticercosis: findings in 30 
cases. Ann OphthalmoI 1992; 24:25–28.  
[138] Alarcon F, Vanormelingen K, Moncayo J, Vinan I. Cerebral cysticercosis as a risk factor 
for stroke in young and middle–age people. Stroke 1992;23:1563–1565.  
[139] Dantas FL. Fagundes-Pereyra WJ, De Souza CT, Vega MG, De Souza AA. 
Intramedullary cysticercosis: case report Arq Neuropsiquiatr 1999;57(2A):301-305.     
[140] Musumdar D, Nadkarni T, Desai K, Dindorkar K, Goel A. Thoracic intramedullary 
cysticercosis. Neurol Med Chir (Tokyo)2002; 42 :575-579.  
[141] Gallani NR, Zambelli HJ, Roth-Vargas AA, Limoli Júnior C.Spinal cord cysticercosis: 
report of 2 cases, review of the literature, and comments on its pathogeny. Arq 
Neuropsiquiatr. 1992 Sep;50(3):343-350. 
[142] Mohanty A, Venkatrama SK, Das S. Spinal intramedullary cysticercosis. Neurosurgery. 
1997;40(1):82–87. 
[143] Chang GY, Keane JR. Visual loss in cysticercosis: analysis of 23 patients. Neurology. 
2001;57:545–548. 
[144] Kishore LT, Gayatri K, Naidu MR, Mateen MA, Dinakar I, Ratnakar KS. 
Intramedullary spinal cord cysticercosis-a case report and literature review. Indian J 
Pathol Microbiol. 1991;34:219–221.  
[145] Isidro-Llorens A, Dachs F, Vidal J, Sarrias M. Spinal cysticercosis. Case report and 
review. Paraplegia. 1993;31:128–130. 
 Novel Aspects on Cysticercosis and Neurocysticercosis 242 
[146] Parmar H, Shah J, Patwardhan V. et al. MR imaging in intramedullary cysticercosis. 
Neuroradiology. 2001;43(11):961–967. 
[147] David J. Neurocysticercosis. “Dr. House Series” .Tuesday, February  22, 2011.(Last 
review  on September  22, 2011) Full article is free available at the URL: 
http://mentiraomedicina.blogspot.com/2011/02/neurocisticercosis.html 
[148] Amaya MA, Roa JL. Neurocisticercosis raquídea: Reporte de caso. Rev Colomb Radiol. 
2011;22(1):3134-3137. 
[149] Mathuriya SN, Khosla VK, Vasishta RK et al. Intramedullary cysticercosis: MRI 
diagnosis. Neurol India. 2001;49(1):71–74. 
[150] Ahmad FU, Sharma BS. Treatment of intramedullary spinal cysticercosis: report of 2 
cases and review of literature. Surg Neurol. 2007;67(1):74–77.  
[151] Agrawal R, Chauhan SP, Misra V. et al. Focal spinal intramedullary cysticercosis. Acta 
Biomed. 2008;79(1):39–41. 
[152] Leite CC, Jinkins JR, Escobar BE, et al. MR imaging of intramedullary and intradural- 
extra medullary spinal cysticercosis. AJR 1997;169:1713-1717. 
[153] Tacconi L, Arulampalam T, Johnston FG. et al. Intramedullary spinal cord abscess: 
case report. Neurosurgery. 1995;37(4):817–819. 
[154] Clifton AG, Stevens JM, Kapoor R. et al. Spinal cord sarcoidosis with intramedullary 
cyst formation. Br J Radiol. 1990;63(754):805–808. 
[155] Lamejjati M, Aniba K, Haddi M. et al. Spinal Intramedullary arachnoid cyst in 
children. Pediatr Neurosurg. 2008;44(3):243–246.  
[156] Iwahashi H, Kawai S, Watabe Y. et al. Spinal Intramedullary ependymal cyst: a case 
report. Surg Neurol. 1999;52(4):357–361.  
[157] Riviérez M, Buisson G, Kujas M. et al. Intramedullary neurenteric cyst without any 
associated malformation. One case evaluated by RMI and electron microscopic study. 
Acta Neurochir. 1997;139(9):887–890. 
[158] Rahalkar MD, Shetty DD, Kelkar AB, et al. The many faces of cysticercosis. Clin Radiol. 
2000;55:668-674. 
[159] Thurnher MM, Cartes-Zumelzu F, Mueller-Mang C, et al. Demyelinating and 
infectious diseases of the spinal cord. Neuroimaging Clin N Am. 2007;17:37-55. 
[160] Colli B, Morales M, Carlotti C, Rubens H, Assirati J. Spinal cord cysticercosis: 
neurosurgical aspects. Neurosurg Focus (e-journal) 2002; 12 (6): available at the URL 
http://www.medscape.com/viewpublication/65_toc?vol=12 & iss=6. (Last review on 
August 09, 2012) 
[161] Villanueva M, Alcocer JL, Martinez J, Horna A. Cisticercosis intramedular. Reporte de 
un caso. Arch Neurocien 2004;9(2):110-113.  
[162] Ichiro A. Tetsuji F, Hitoshi M, Hideo M, Masakuni K. Intramedullary spinal 
cysticercosis. Neurology 1979; 29: 1531-1534.          
[163] Alsina GA, Johnson JP, Mc Bride DQ, et al. Spinal neurocysticercosis. Neurosurg Focus 
2002: 12(6):e8. 
[164] Izci Y, Moftakhar R, Salamat MS, Baskaya MK.Spinal intramedullary cysticercosis of 
the conus medullaris.WMJ 2008;107(1):37-39. 
 
Uncommon Clinical Manifestations of Cysticercosis 243 
[165] Mathuriya SN, Khosla VK, Vasishta RK, Tewari MK, Pathak A, Prabhakar 
S.Intramedullary cysticercosis : MRI diagnosis. Neurol India. 2001;49(1):71-74. 
[166] Vij M, Jaiswal S, Jaiswal AK, Behari S.Coexisting intramedullary schwannoma with 
intramedullary cysticercus: report of an unusual collision. Indian J Pathol Microbiol. 
2011;54(4):866-867. 
[167] Wadia N, Desai S, Bhatt M: Disseminated cysticercosis. New observations, including 
CT scan findings and experience with treatment by praziquantel. Brain 1988, 111:597-
614. 
[168] Bhalla A, Sood A, Sachdev A,   Varma V. Disseminated cysticercosis: a case report and 
review of the literature Medical Case Reports 2008; 2:137-140. Full article is available at 
the URL: http://www.jmedicalcasereports.com/content/2/1/137 (Last access on August 
10, 2012) 
[169] Flisser A. Cisticercosis subcutáneo. Ciencias, UNAM 2011. Available at the URL: 
http://hydra.fciencias.unam.mx:8080/xmlui/handle/123456789/62343?show=full (last 
accessed on August 11, 2012) 
[170] Patel R, Jha S, Yadav RK.Pleomorphism of the clinical manifestations of 
neurocysticercosis. Trans R Soc Trop Med Hyg. 2006;100(2):134-141.  
[171] Sawhney IM, Singh G, Lekhra OP, Mathuriya SN, Parihar PS, Prabhakar S. 
Uncommon presentations of neurocysticercosis. J Neurol Sci. 1998;154(1):94-100. 
[172] Kahn P. Cysticercosis of the central nervous system with amyotrophic lateral sclerosis: 
case report and review of the literature. J Neurol Neurosurg Psychiatry. 1972;35(1):81-
87. 
[173] Revuelta Gutierrez R, Soto-Hernández JL, Suastegui-Roman R, Ramos-Peek J. 
Transient hemifacial spasm associated with subarachnoid brainstem cysticercosis: a 
case report. Neurosurg Rev.1998;21(2-3):167-170. 
[174] Kim JS, Jeong SM, Moon SY, Park SH. Third cranial nerve palsy from midbrain 
neurocysticercosis: repeated exacerbation on tapering corticosteroids. J 
Neuroophthalmol. 2004 Sep;24(3):217-220. 
[175] Lath R, Rajshekhar V. Solitary cysticercus granuloma of the brainstem. Report of four 
cases. J Neurosurg. 1998;89(6):1047-1051. 
[176] Singh NN, Verma R, Pankaj BK, Misra S. Neurocysticercosis presenting as Weber's 
syndrome. Neurol India. 2003;51(4):551-552. 
[177] Chotmongkol V, Sawanyawisuth K, Limpawattana P, Phuphatham A, Chotmongkol 
R, Intapan PM. Superior divisional oculomotor nerve palsy caused by midbrain 
neurocysticercosis. Parasitol Int. 2006;55(3):223-225.  
[178] Ranjith MP, Divya R, Sahni A. Isolated one and a half syndrome: An atypical 
presentation of neurocysticercosis. Indian J Med Sci [serial online] 2009 [cited 2012 Aug 
13];63:119-120. Available from:  
http://www.indianjmedsci.org/text.asp?2009/63/3/119/49291 
[179] Song TJ, Suh SH, Cho H, Lee KY.Claude's syndrome associated with 
neurocysticercosis. Yonsei Med J. 2010;51(6):978-979. 
 Novel Aspects on Cysticercosis and Neurocysticercosis 244 
[180] Naphade PU, Singh MK, Garg RK,  Rai D. Bilateral ptosis: an atypical presentation of 
neurocysticercosis. BMJ Case Reports.2012; doi:10.1136/bcr-2012-006195  
http://casereports.bmj.com/content/2012/bcr-2012-006195.abstract 
[181] Keane JR. The Pretectal Syndrome: 206 Patients. Neurol 1990;40:684-690 
[182] Garg RK, Karak B. Neurocysticercosis presenting as midbrain syndrome. J Assoc 
Physicians India. 2000;48(5):533-535. 
[183] Ranjith MP, Divya R, Sahni A.Isolated third cranial nerve palsy: a rare presentation of 
neurocysticercosis. Ir J Med Sci. 2011;180(4):905-907. 
[184] Singhi P, Mahajan V, Khandelwal NK. Sudden-onset ptosis caused by midbrain 
neurocysticercosis in 2 children. J Child Neurol. 2008 Mar;23(3):334-337.  
[185] Bolaños I, Lozano D, Cantú C. Internuclear ophthalmoplegia: causes and long-term 
follow-up in 65 patients. Acta Neurol Scand. 2004;110(3):161-165. 
[186] Foyaca-Sibat H, Ibanez-Valdes LdeF.One-and-a half syndrome. Clinical Classification. 
/ Electron J Biomed 2004;3:15-21. http://biomed.uninet.edu/2004/n3/foyaca.html 
[187] Arruda WO, Ramina R, Pedrozo AA, et al. Brainstem cysticercosis simulating cystic 
tumor lesion. A case report. Arq Neuropsiquiatr 1994;52:431- 434. 
[188] Bhatia R, Desai S, Garg A, Padma MV, Prasad K, Tripathi M. Isolated facial myokymia 
as a presenting feature of pontine neurocysticercosis. Mov Disord. 2008;23(1):135-137. 
[189] Garg RK. Wallenberg's lateral medullary syndrome: a new non-vascular cause. J Assoc 
Physicians India. 1999;47(11):1110-1111. 
[190] Aguiar PH, Miura FK, Napoli PR, Sendenski M, Rotta JM, Cescato VN, Teixeira MJ, 
Marino Junior R. Unusual cause for bilateral trigeminal neuralgia: unilateral racemous 
cysticercus of cerebellopontine angle. Case report. Arq Neuropsiquiatr. 2000;58(4):1138-
1141. 
[191] Nadkarni T, Kansal R, Goel A. Right cerebellar peduncle neurocysticercosis presenting 
with bradycardia. Acta Neurochir (Wien). 2010;152(4):731-732.  
[192] Damasio A, Damasio H, Tranel D.Persistence of Feelings and Sentience after Bilateral 
Damage of the Insula. Cereb. Cortex (2012) doi: 10.1093/cercor/bhs077 First published 
online: April 3, 2012.  
http://cercor.oxfordjournals.org/content/early/2012/04/03/cercor.bhs077.short 
[193] Marshall R, Lazar R, Mohr JP, Van Heertum R, Mast H. "Semantic" conduction aphasia 
from a posterior insular cortex infarction. J Neuroimaging. 1996;6:189-191.  
[194] Colivicchi F, Bassi A, Santini M, Caltagirone C. Cardia autonomic derangement and 
arrhythmias in right sided stroke with insular involvement. Stroke 2004;35:2094-2098. 
[195] Massetani R, Strata G, Galli R, Gori S, Gneri C, et al., Alteration of Cardiac Function in 
Patients with Temporal Lobe Epilepsy: Different Roles of EEG-ECG Monitoring and 
Spectral Analysis of RR Variability. Epilepsia 1997;38(3):363-369. 
[196] Locatelli ER, Varghese J, Shuaib A, Potolicchio SJ. Cardiac Asystole and bradycardia as 
a manifestation of left temporal lobe complex partial seizure. Ann Intern Med 
1999;130:581-583. 
 
Uncommon Clinical Manifestations of Cysticercosis 245 
[197] Druschky A, Hilz MJ, Hopp P, Platsch G, et al. Interictal cardiac autonomic 
dysfunction in temporal lobe epilepsy demonstrated by [123I]metaiodobenzylguanidine-
SPECT. Brain 2001;124(12):2372-2382. 
[198] Ansakorpi H, Korpelainen JT, Huikuri HV, Tolonen U, Myllylä VV,  Isojärvi JIT. Heart 
rate dynamics in refractory and well controlled temporal lobe epilepsy. J Neurol 
Neurosurg Psychiatry 2002;72:26–30. 
[199] Koseoglu E, Kucuk E, Arman F, Ersoy AO. Factors that affect interictal cardiovascular 
autonomic dysfunction  in temporal lobe epilepsy: Role of hippocampal sclerosis. 
Epilepsy & Behavior 2009;16(4): 617–621. 
[200] Nouri S. Epilepsy and the Autonomic Nervous System. (2010) Full article is availale at 
the URL: http://emedicine.medscape.com/article/1186872-overview. 
[201] Park YS, Lee YH, Shim KW, Lee YL, Kim HD, Lee J-S, Kim D-S. Insular epilepsy 
surgery under neuronavigation guidance using depth electrode. Childs Nerv Syst 
((2009) 25:591–597. 
[202] Von Lehe M, Wellmer J,  Urbach H, Schramm J, Elger CE and H. Clusmann. Insular 
lesionectomy for refractory epilepsy: management and outcome. Brain 2009: 132; 1048–
1056. 
[203] Meng H, Yudan LV, Cui l, Wang Z, Kin W, et al. Hypothalamus mediates the 
cardiovascular changes induced by insular epilepsy. Human Health and Biomedical 
Engineering (HHBE), 2011 International Conference on 19-22 Aug. 2011. Available at 
the URL: 
http://ieeexplore.ieee.org/xpl/login.jsp?tp=&arnumber=6027962&url=http%3A%2F%2Fi
eeexplore.ieee.org%2Fxpls%2Fabs_all.jsp%3Farnumber%3D6027962 
[204] Enríquez Coronel E, Santos Marcial E, Cabrera Aldana EE. Cerebral cycticercosis 
vasculitis and optic neuropathy. Case report. Arch. Neurocien (Mex., D.F.) 2004;9(3): 
[205] Salcedo-Villanueva G, Rueda-Villa A, Hernández-Ábrego MP. Hemianopsia 
bitemporal secundaria a hidrocefalia por neurocisticercosis. Archivos de la Sociedad 
Española de Oftalmología. Full article is free available at the URL:  
http://linkinghub.elsevier.com/retrieve/pii/S0365669112003401?via=sd&cc=y 
[206] Kufs T, von basaler F. Cysticerkenmeningitis mit Cysticercus der Hypophhysis und 
schwerer depressiver Psychose. Z. Ges.Neurol. Psych., 1915;30:286-304.(Cited by Prosser 
PR) 
[207] Dickinson, C. J. Cysticercosis and panhypopituitarism. Proc. R. Soc. Med., 1955; 48:892. 
[208] Argenta, G., 1956. Su di un caso di cisticercosis generalizata con sindrome di adenoma 
ipofisario. Riv. Neurol. (Napoli). 1956;26:197-204. 
[209] Briceflo, C. E., Biagi, F., and Martinez, B.,.Cysticercosis. Observaciones sobre 97 casos 
de autopsia. Prensa Med. Mex., 1961;26:193-197. 
[210] Prosser PR, Wilson CB, Forsham PH. Intrasellar cysticercosis presenting as a pituitary 
tumor: successfully transphenoidal cystectomy with preservation of pituitary function. J 
Trop Med Hyg.1978;27(5):976-979.  
[211] Gómez-Llata RH. Intrasellar cysticercosis. J Neurosurg 1985;63:975–976. 
[212] Del Brutto OH, Guevara J, Sotelo J. Intrasellar cisticercosis. J Neurosurg 1988;69:58–60. 
 Novel Aspects on Cysticercosis and Neurocysticercosis 246 
[213] Arriada-Mendicoa N, Celis-López MA, Higuera-Calleja J, Corona-Vázquez T. Imaging 
features of sellar cysticercosis. Am J Neuroradiol. 2003;24(7):1386-1389. 
[214] Rohilla S, Rawal M, Yadac RK, Ahula A, Nanda S, Dhaulakhandi DB. 
Neurocysticercosis-presenting-as-central-diabetes-insipidus-in-a-boy J Pediat Neurol 
2009;7(3):307-310. Full article is available at the URL:  
http://www.docstoc.com/docs/44022185/Neurocysticercosis-presenting-as-central-
diabetes-insipidus-in-a-boy 
[215] Jin Hwan Cheong, M.D., Jae Min Kim, M.D., Choong Hyun Kim, M.D. 
Neurocysticercosis Involving the Pituitary Stalk :Case Report and Literature Review. J 
Korean Neurosurg Soc 2010;48:91-93.  
[216] Kelesidis T, Tsiodras S. Hypopituitarism caused by neurocysticercosis. Am J Med Sci. 
2011;341(5):414-416. 
[217] Del Brutto OH, Sotelo J, Román GC. Neurocysticercosis: A Clinical Handbook. Lisse, the 
Netherlands: Swets & Zeitlinger;1998. 
[218] Del Brutto OH, Sotelo J. Some unusual manifestations of neurocysticercosis. Rev Neurol 
Neurosurg Psychiatry (Mexico) 1989;29:23–26. 
[219] Madrazo I, Sandoval M, González D. Evaluation of the hypothalamic-hypophyseal 
axis in patients with hypertensive hydrocephalus due to neurocysticercosis. Arch Invest 
Med (Mex). 1991 Apr-Jun;22(2):113-115. 
[220] Lino RS Jr, Reis MA, Teixeira VP. Occurrence of encephalic and cardiac cysticercosis 
(Cysticercus cellulosae) in necropsy. Rev Saude Publica. 1999;33(5):495-498. 
[221] Júnior Lino RS, Reis LC, Reis MA, Gobbi H, Teixeira VP. Hypothalamic 
neurocysticercosis as a possible cause of obesity. Trans R Soc Trop Med Hyg. 2000 
;94(3):294. 
[222] Prajej R, Thananat B, · Pasiri S,  Yupin B, Warin ·Ch, Suchinta  U, Thanom S. 
Hypothalamic neurocysticercosis presenting. with polyuria: a first report of an unusual 
manifestation. Nephrol Dial Transplant. 2006;21:2308–2310. 
[223] Garg RK, Malhotra HS. Solitary cysticercus granuloma. Expert Review of Anti-
infective Therapy. 2012;10(5):597-612.  
[224] Maguire JH, Tierney MR. Case records of the Massachusetts General Hospital. Weekly 
clinicopathological exercises. Case 8-1993. A 62-year-old Cape Verdean woman with 
blurred vision, diplopia, a suprasellar mass, and lymphocytic meningitis. N Engl J Med 
1993; 328: 566–573. 
[225] Amaral L, Maschietto M, Maschietto R, Cury R, Ferreira NF, Mendonça R, Lima SS. 
Ununsual manifestations of neurocysticercosis in MR imaging: analysis of 172 cases. 
Arq Neuropsiquiatr. 2003;61(3A):533-541. 
[226] Prasad R, Singh R, Joshi B. Lateral sinus thrombosis in neurocysticercosis. Trop Doct. 
2005;35(3):182-183. 
[227] Sethi PK, Sethi NK, Torgovnick J, Arsura E. Cysticercosis of temporalis muscle: an 
unusual cause of temporal headaches. A case report. J Headache Pain. 2007;8(5):315-317. 
[228] Kumar V, Gulati A, Mehra B. Cysticercosis of the temporalis muscle causing temporal 
headache in a pregnant woman.Int J Gynaecol Obstet. 2011;114(1):79.  
 
Uncommon Clinical Manifestations of Cysticercosis 247 
[229] Sarma DP, Omaha MD. Biopsy of a 1.5-cm cystic lesion on the right cheek of a 28-year-
old man. Available at URL: http://www.scribd.com/doc/93186763/Cutaneous- 
Cysticercosis. 
[230] Sidhu R, Nada R, Palta A, Mohan H, Suri S. Maxillofacial cysticercosis: uncommon 
appearance of a common disease. J Ultrasound Med 2002; 21:199–202. 
[231] Pinswasdi P, Charoensiri DJ. Cysticercosis in labial tissue. Case report. Aust Dent J. 
1997;42(5):319-321. 
[232] Mazhari NJ; Kumar N; Jain S. Cysticercosis of the oral mucosa: aspiration cytologic 
diagnosis. J Oral Pathol Med 2001; 30:187-189.  
[233] de Souza PEA, Barreto DC, da Silva Fonseca LM, Batista de Paula AM, Silva EC, 
Gomez RS. Cysticercosis of the oral cavity: report of seven cases. Oral Diseases. 
2000;6(4): 253–255. 
[234] Bhandary S, Sury R, Karki P, Sinha AK: Cysticercosis of Tongue-diagnostic dilemma; 
Pac Health Dialog. 2004;11(1): 87-88. 
[235] Corona S, Apt W. Multiple hydatid cysts and generalized cysticercosis. Rev Med Chil 
1989;117:311-314. 
[236] Natarajan A, Rameshkumar K, D’Souza RE. Cysticercosis masquerading as a salivary 
gland neoplasm. Trop Doct 2002;32:120-121. 
[237] Chakraborty PP , Bhattacharjee R, Chatterjee K. Parotid Gland Cysticercosis. 2007;55: 
[238] Veena G, Shon GM, Usha K, NayarRC. Extracranial cysticercosis of the parotid gland: 
a case report with a review of the literature. The Journal of Laryngology & Otology 
2008;122(9):1008-1011. 
[239] Leelachaikul, Chuahirun S. Cysticercosis of thyroid gland in severe cerebral 
cysticercosis: report of a case. J Med Assoc Thai 1977;60:405–10. 
[240] Scholtz L, Mentis H. Pulmonary cysticercosis. SAMT1987; 72( 1): 573. 
[241] Smiti S,  Sripathi H, Naik L. Cricothyroid muscle cysticercosis. Muscoloskeletal 2003:  
13(2):157-158. 
[242] Sobnach S, Khosa SA, Pather S, Longhurst S, Kahn D, Raubenheimer PJ. First case 
report of pharyngeal cysticercosis. Trans R Soc Trop Med Hyg. 2009;103(2):206-208. 
[243] Sodhi PK, Ratan SK. Submandibular lymph node enlargement due to cysticercosis 
infestation. Scandinavian journal of infectious diseases. 2004;36: 227-229. 
[244] Geeta V, Devi P, Sirisha A, Devi R, Bai J, Kumar S. Unusual location of Cysticercosis 
lesion presentation. JEMDS 2012;42. Article is fully available at the URL: 
http://www.jemds.com/latest-articles.php?at_id=42 (Last checked on August 27, 2012) 
[245] Vikas Sinha V,  Raizada RM, Jain SKT, Chaturvedi VN. Cysticercosis of 
Submandibular Duct. Indian Journal of Otolaryngology and Head & Neck Surgery. 
1999;51(4):51-52.  
[246] Sharma R, Gautam P, Kumar S, Elhence P,  Bansal R, et al. Isolated Cysticercosis 
Cellulosae of Sternocleidomastoid Muscle: A Case Report with Review of Literature. 
Indian Journal of Otolaryngology and Head & Neck Surgery 2011;24:127-130. 
[247] Thomas MB, Thomas KM, Awotedu AA, Blanco-Blanco E, Anwary M. Cardiocysticercosis.S 
Afr Med J 2007;97(7):504-505.  
 Novel Aspects on Cysticercosis and Neurocysticercosis 248 
[248] Eberly MD, Soh EK, Bannister SP, Taraf-Motamen H, Scott JS: Isolated Cardiac 
Cysticercosis in an adolescent; Pediatr Infect Dis J. 2008; 27(4); 369-71. 
[249] Jain BK, Sankhe SS, Agrawal MD, Naphade PS. Disseminated cysticercosis with 
pulmonary and cardiac involvement. Indian J Radiol Imaging 2010;20:310-313. 
[250] Mamere AE, Muglia VF, Simao GN, Belucci AD, Carlos dos Santos A, Trad CS, et al. 
Disseminated cysticercosis with pulmonary involvement. J Thorac Imaging 
2004;19:109–111. 
[251] Bhigjee AI. Disseminated cysticercosis. J Neurol Neurosurg Psychiatry 1999;66(4):545 
[252] Banu A, Veena N. A rare case of disseminated cysticercosis: Case report and literature 
review. Case Report. 2011;29(2):180-183. 
[253] Kumar A,  Goenka AH, Choudhary A, Kumar Sahu JK,  Gulati S.Disseminated 
cysticercosis in a child: whole-body MR diagnosis with the use of parallel imaging. 
Pediatric Radiology 2110;45:223-227. 
[254] Smiti S,  Sripathi H, Naik L. Pectoralis Major muscle cysticercosis. 
MUSCULOSKELETAL 2003;13(2):157-158. 
[255] Wadia N, Deasi S, Bhat M. Disseminated cysticercosis; new observations, including CT 
scan finding and experience with treatment by praziquantel. Brain 1988; 111: 597-614. 
[256] Saxena H, Samuel KC, Singh B. Cysticercosis of the heart. Indian Heart J 1972;24: 313-
315. 
[257] Niakara A, Cisse R, Traore A, et al. Myocardial localization of a disseminated 
cisticercosis. 
[258] Cutrone JA, Georgiou D, Gil-Gomez C, Burndage BH. Myocardial cysticercosis 
detected by ultrafast CT. Chest 1995; 108:1752-1754. 
[259] Rahalkar MD, Shetty DD, Kelkar AB, Kelkar AA, Kinare AS, Ambardekar ST. The 
many faces of cysticercosis. Clin Radiol 2000; 55 (9): 668-674. 
[260] Ibarra-Perez C, Fernandez-Diez J, Rodriguez-Trujillo F. Myocardial cysticercosis, 
report of two cases with coexisting heart disease. South Med J 1972; 65: 484-486. 
[261] Deshpande VL, Patil SD. Silent myocardial cysticercosis. Indian Heart J 1976; 28(1): 58-
60. 
[262] Belagavi CS, Goravalingappa JP. Cysticercosis of the heart. A case report. Indian Heart 
J 1978;30: 118-119.)  
[263] Kirchhoff LV, Weiss LM, Wittner M, Tanowitz HB. Parasitic diseases of the heart. 
Front Biosci. 2004;9:706-723. 
[264] Fan PC, Chung WC, Guo JX, Ma YX, Xu ZJ. Experimental studies on physiological and 
morphological aspects of Cysticercus cellulosae in pigs. J Microbiol Immunol Infect. 
2001;34(4):252-258. 
[265] Franco-Paredes C, Rouphael N, Méndez J, Folch E, Rodríguez-Morales AJ, Santos JI, 
Hurst JW. Cardiac manifestations of parasitic infections part 3: pericardial and 
miscellaneous cardiopulmonary manifestations. Clin Cardiol. 2007;30(6):277-280. 
[266] Franco-Paredes C, Rouphael N, Méndez J, Folch E, Rodríguez-Morales AJ, Santos JI, 
Hurst JW. Cardiac manifestations of parasitic infections part 1: overview and 
immunopathogenesis. Clin Cardiol. 2007;30(4):195-199. 
 
Uncommon Clinical Manifestations of Cysticercosis 249 
[267] Hidron A, Vogenthaler N, Santos-Preciado JI, Rodriguez-Morales AJ, Franco-Paredes 
C, Rassi A Jr. Cardiac involvement with parasitic infections. Clin Microbiol Rev. 2010 
;23(2):324-349. 
[268] Salaria M, Parmar V, Kochar S, Mehta S. Eosinophilia, Pleural Effusion and 
Cysticercosis - Unknown Association? Indian Pediatrics 2001; 38: 671-674. 
[269] Mayo F, Baier H. Cysticercotic cyst involving the pleura. An unusual case of an 
abnormal chest roentgenogram. Arch Intern Med. 1979;139(1):115-116. 
http://www.scielo.br/scielo.php?pid=S0036-46651991000200007&script=sci_abstract 
[270] Yaqoob N, Haq EU,Thomali K, Kamran A, Zaharani A. Cysticercosis of Soft Tissue 
(BREAST). Journal of Pakistan Medical Association.2009;59(2):108-110. 
[271] Agnihotri S, Talwar OP, Pudasaini S, Baral R. Cysticercosis of breast - a case report. 
Pol J Pathol 2006; 57:53-54. 
[272] Lucarelli AP,  Martins MM, Marques de Oliveira V, Rinaldi JF, Roveda Jr D., Longo 
Galvão MA, et al. Cysticercosis of the Breast, a Rare Imaging Finding. Am. J. Trop. Med. 
Hyg.,2008;79(6):864–865. 
[273] Chew NK, TAN CT, GOH KJ, Kamarulzaman A, Paul G, Ramli N, Anuar K. The first 
case of neurocysticercosis diagnosed ante-mortem in Malaysia. Neurol J Southeast Asia 
2001;7:135–138. 
[274] Mani NB, Kalra N, Jain M, Sidhu R. Sonographic diagnosis of a solitary intramuscular 
cysticercal cyst. J Clin Ultrasound 2001; 29:472-475.  
[275] Inamadar AC, Yelikar BR. Cysticercosis cellulose cutis. Indian J Dermatol Venereol 
Leprol. 2001 Jul-Aug;67(4):198-189. 
[276] Abdelwahab IF, Klein MJ, Hermann G, Abdul-Quader M. Solitary cysticercosis of the 
biceps brachii in a vegetarian: a rare and unusual pseudotumor. Skeletal Radiol 2003; 
32:424-428.  
[277] Yamasaki H, Nagase T, Kiyoshige Y, Suzuki M, Nakaya K, Itoh Y, et al. A case of 
intramuscular cysticercosis diagnosed definitively by mitochondrial DNA analysis of 
extremely calcified cysts. Parasitol Int 2006; 55:127-30.  
[278] Nagaray C, Singh S, Joshi A, Trikha V: Cysticercosis of biceps brachii: a rare cause of 
Posterior Interosseous nerve syndrome; Joint Bone Spine. 2008;75(2):219-221. 
[279] Jankharia B, Chavan G, Krishnan, Jankharia B: MRI and Ultrasound in solitary 
muscular and soft tissue cysticercosis; Skeletal Radiol.2005; 34: 722-726. 
[280] Mani NBS , Kalra N et al Sonographic diagnosis of solitary intramuscular Cysticercal 
cyst. J clin ultrasound. 2001;29:472-475. 
[281] Tripathy SK, Sen RK, Sudes P, Dhatt S. Solitary cysticercosis of deltoid muscle in a 
child: The diagnostic dilemma and case report. J of Orthopaedics 2009;6:e11.  
[282] Asrani A, Morani A. Primary sonographic diagnosis of disseminated muscular 
cysticercosis. J Ultrasound Med 2004;23:1245-1248.  
[283] Jhankaria BG, Chavhan GB, Krishnan P, Jhankaria B. MRI and ultrasound in solitary 
muscular and soft tissue cysticercosis. Skeletal Radiol 2005;34:722-726.  
[284] Sirikulchayanonta V, Jaovisidha S. Correlation of Magnetic Resonance Imaging and 
Histopathology. J Med Assoc Thai 2007;90(6):1248-1252. 
 Novel Aspects on Cysticercosis and Neurocysticercosis 250 
[285] Smiti S, Sripathi H, Naik L.Cysticercosis in the right thigh. MUSCULOSKELETAL 
2003;13(2):157-158. 
[286] Sirikulchayanonta V, Sirikulchayanonta Ch, Leopairat J.A Descriptive study of 36 
cases of solitary soft tissue cysticercosis at Ramathibodi Hospital. Southeast Asian J 
Trop Med Public Health. 2007;38(3): 407. 
[287] Yamasaki H, Nagase T, Kiyoshige Y, Suzuki M, Nakaya K, Itoh Y, et al. A case of 
intramuscular cysticercosis diagnosed definitively by mitochondrial DNA analysis of 
extremely calcified cysts. Parasitol Int. 2006;55:127-130.  
[288] Inamadar AC, BR Yelikar BR. Cysticercosis cellulose cutis. Indian J Dermatol Venereol 
Leprol 2001;67(4):198-199. 
[289] Ogilvie CM, Kasten P, Rovinsky D, Workman KL, Johnston JO. Cysticercosis of the 
triceps: an unusual pseudotumor. Clin Orthop 2001; 382:217–221. 
[290] Akhtar MN, Sharat Agarwal S.Disseminated cysticercosis incidentally diagnosed in a 
patient of low backache: a case report and concise review of literature. Asian Pac J Trop 
Med Jul 2012. 
[291] Foyaca-Sibat H, Ibanez-Valdes LdeF, Mashiyi MK. Disseminated cysticercosis. One 
day treatment in a case. Electron J Biomed 2004;3:39-43. http://www.biomed.edu/2004/ 
n1/foyaca.html  
[292] Park SY, Min HK, Jung HK, Kwan YS. Disseminated cysticercosis. Journal of Korean 
Neurosurgical Society. 2011;49(3):190-193.  
[293] Sirikulchayanonta V, Jaovisidha S: An intramuscular cysticercosis, a case report with 
correlation of magnetic resonance imaging and histology; J Med Assoc Thai. 
2007;90(6):1248-1252. 
[294] Jacob JC, Mathew NT, 1968. Pseudohypertrophic myopathy in cysticercosis. Neurology 
18: 767–771. 
[295] Gill M, Dua S, Gill P, Gupta V, Gupta S, Sen R . Cytomorphological spectrum of 
subcutaneous and intramuscular cysticercosis: A study of 22 cases. J Cytol 2010; 
27(4):123-126. 
[296] Sawhney BB, Chopra JS, Banerji AK, Wahi PL, 1976. Pseudohypertrophic myopathy in 
cysticercosis. Neurology 1976;26:270–272. 
[297] Armbrust-Figueiredo J, Speciali JG, Lison MP, 1970. Forma miopatica da cisticercose. 
Arq Neuropsiquiatr 28: 385–390. 
[298] Naik D, Srinath MG, Kumar A.Soft tissue cysticercosis - Ultrasonographic spectrum of 
the disease. Indian Journal of Radiology and Imaging. 2011;21(1):60-62.  
[299] GA Anderson, SM Chandi: Cysticercosis of the Flexordigitorum profundus muscle 
producing flexion deformity of the fingers; J of Hand Surgery (British & European 
Volume), 1993; Vol.18, No.3; 360-36. 
[300] Sharat Agarwal, Paragjyoti Gogoi: An unusual case of Cysticercosis of the tendon 
sheath of Tendoachilles – A case report; Electronic Physician. 2010; 2: 45-48. 
[301] Ray M, Kothur K. Entrapment ulnar neuropathy caused by cysticercosis. Journal of 
Pediatric Neurology. 2006;4(3):203-206. 
 
Uncommon Clinical Manifestations of Cysticercosis 251 
[302] Kurrein F, Vickers AA. Cysticercosis of the spine. Ann Trop Med Parasitol. 1977 
;71(2):213-217. 
[303] Kumar P,AnsariJA, Dwivedi S, Sinha AK. Peripheral Joint Pain, Hypertension, Multiple 
Skeletal and CNS Calcific Lesions. JIACM 2002; 3(2):148-152. 
[304] Banu A, Veena N A rare case of disseminated cysticercosis: case report and literature 
review. Indian J Med Microbiol 2011 Apr-Jun; 29(2):180-1833. 
[305] Mani NB, Kalra N, Jain M, Sidhu R. Sonographic diagnosis of a solitary intramuscular 
cysticercal cyst. J Clin Ultrasound 2001; 29:472-475.  
[306] Bangal V , Kwatra A, Garg S. Rare case of cysticercosis of rectus abdominis muscle 
presenting as pelvi abdominal lump during puerperium. Pravara Med Rev 2010; 5(2):21-
24. 
[307] Khan RA, Wahab S, Chana RS A. Rare Cause of Solitary Abdominal Wall Lesion. Iran J 
Pediatr. 2008;18(3):291-292. 
[308] Mittal A, Sharma NS 2008 Sep : Psoas muscle cysticercosis presenting as Acute 
Appendicitis; J Clin Ultrasound. 2008 Sep; 36(7): 430-431.  
[309] Mohan H, Bal A, Aulakh R. Multiple cysticerci as an unusual cause of mesenteric 
lymph node enlargement: a case report. Journal of Medical Case Reports 2008,2:196. 
[310] Vianna LG, Macedo V, Costa JM. Cutaneous, muscular and visceral cysticercosis - a 
rare disease? Rev. Inst. Med. trop. S. Paulo 1991;33(2):129-136.  
[311] G Everett, de Gruchy PH. Hepatic cysticercosis Veterinary Record 1982;111:24 565. 
[312] Fultz PJ, Penwarden B, Laczin J.Hepatic cysticercosis. Report of an unusual case. J Clin 
Gastroenterol. 1995;20(2):160-163. 
[313] Figurnov VA, Churin AN, Lenshin AV, Grigorenko AA, Churina SA, Figurnova EV, 
Soldatkin PK. .A case of isolated hepatic cysticercosis in a nine-year-old girl. Med 
Parazitol (Mosk). 2002 ;(1):56-57. 
[314] Vishwanath S, Charudutt S, Kavitha S, Abdul R, Ashwin P, Rao SN. (2011) A rare case 
of hepatic cysticercosis. Asian Pacific Journal of Tropical Biomedicine 2011;1(1)139-140. 
[315] Bal MS, Suri A, Kumar R, Vijay M. Disseminated cysticercosis in a post mortem case. J 
Punjab Acad Forensic Med Toxicol 2012;12(1):40. 
[316] Jain BK, Sankhe SS, Agrawal MD, Naphade PS.Disseminated cysticercosis with 
pulmonary and cardiac involvement. Indian J Radiol Imaging. 2010; 20(4):310–313. 
[317] Jakhere SG, Chemburkar VC, Yeragi BS, Bharambay HVImaging findings of 
disseminated cysticercosis with unusual involvement of spleen and pancreas. J Glob 
Infect Dis 2011;3(3):306-308. 
[318] Bal MS, Suri A, Kumar R, Vijay M. Disseminated cysticercosis in a post mortem case. J 
Punjab Acad Forensic Med Toxicol 2012;12(1):40. 
[319] Norman RJ. Tetraphyllidean cysticerci in the peritoneal cavity of the common dolphin. 
J Wildl Dis. 1997;33(4):891-895. 
[320] Chung WC, Lin CY, Fan PC. Ectopic locations of Taenia saginata asiatica cysticerci in 
the abdominal cavity of domestic pig and monkey. J Parasitol. 1996;82(6):1032-1034. 
[321] Dyer NW, Greve JH. Severe Cysticercus Longicollis Cysticercosis in a Black Lemur 
(Eulemur Macaco Macaco. J VET Diagn Invest 1998;10:362. 
 Novel Aspects on Cysticercosis and Neurocysticercosis 252 
[322] Fraga CM, Costa TL, Bezerra JC, de Souza Lino Junior R, Vinaud MC.Fatty acids 
oxidation and alternative energy sources detected in Taenia crassiceps cysticerci after 
host treatment with antihelminthic drugs. Exp Parasitol. 2012;131(1):111-115. 
[323] Stringer JL, Marks LM, White AC Jr, Robinson P. Epileptogenic activity of granulomas 
associated with murine cysticercosis. Exp Neurol. 2003;183(2):532-536. 
[324] Vincent JM, Morrison ID, Armstrong P, Reznek RH.The size of normal adrenal glands 
on computed tomography. Clin Radiol. 1994;49(7):453-455. 
[325] Rajatanavin R, Dheandhanoo D, Siridej N, Somburanasin R. Cerebral cysticercosis 
simulating pheochromocytoma: a case report. J Med Assoc Thai. 1981;64(7):351-355. 
[326] Liu Y, Wang L. Telemedicine in border area of China. Telemed J. 1998;4(1):39-41. 
[327] Kelesidis T, Tsiodras S. Hypopituitarism caused by neurocysticercosis. Am J Med Sci. 
2011;341(5):414-416. 
